<SEC-DOCUMENT>0001140361-26-022337.txt : 20260521
<SEC-HEADER>0001140361-26-022337.hdr.sgml : 20260521
<ACCEPTANCE-DATETIME>20260521080037
ACCESSION NUMBER:		0001140361-26-022337
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20260519
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20260521
DATE AS OF CHANGE:		20260521

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			VIAVI SOLUTIONS INC.
		CENTRAL INDEX KEY:			0000912093
		STANDARD INDUSTRIAL CLASSIFICATION:	SEMICONDUCTORS & RELATED DEVICES [3674]
		ORGANIZATION NAME:           	04 Manufacturing
		EIN:				942579683
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0627

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-22874
		FILM NUMBER:		261005921

	BUSINESS ADDRESS:	
		STREET 1:		1445 SOUTH SPECTRUM BLVD.
		STREET 2:		SUITE 102
		CITY:			CHANDLER
		STATE:			AZ
		ZIP:			85286
		BUSINESS PHONE:		4084043600

	MAIL ADDRESS:	
		STREET 1:		1445 SOUTH SPECTRUM BLVD.
		STREET 2:		SUITE 102
		CITY:			CHANDLER
		STATE:			AZ
		ZIP:			85286

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	JDS UNIPHASE CORP /CA/
		DATE OF NAME CHANGE:	19990713
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ef20074430_8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2025" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:currency="http://xbrl.sec.gov/currency/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:naics="http://xbrl.sec.gov/naics/2025" xmlns:sic="http://xbrl.sec.gov/sic/2025" xmlns:stpr="http://xbrl.sec.gov/stpr/2025" xmlns:exch="http://xbrl.sec.gov/exch/2025" xmlns:cef="http://xbrl.sec.gov/cef/2025" xmlns:cyd="http://xbrl.sec.gov/cyd/2025" xmlns:viav="http://viavisolutions.com/20260519" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 26.3.2.5342
         Copyright 1995 - 2026 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html"/>
</head>

<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_06b39c0d5a344643bdf0e8639d24e7a4" contextRef="c20260519to20260519" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_b8b2517f44ba42f4bd63cf22aa23e11d" contextRef="c20260519to20260519">0000912093</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="viav-20260519.xsd" xlink:type="simple"/></ix:references><ix:resources><xbrli:context id="c20260519to20260519"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000912093</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-05-19</xbrli:startDate><xbrli:endDate>2026-05-19</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
<div style="line-height: initial;">
  <div><span style="font-size: 10pt;"> </span></div>

  <div>
    <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/>
    <div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">UNITED STATES</div>

      <div><span style="font-size: 14pt;"> </span></div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;">Washington, D.C. 20549</div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">
        <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 18pt; font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_7d04a166a12d44c3b0dcb2c58fa4404b" contextRef="c20260519to20260519">8-K</ix:nonNumeric></div>

        <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">
          <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/> </div>

      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CURRENT REPORT</div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Pursuant to Section 13 or 15(d) of the</div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Securities Exchange Act of 1934</div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><a id="z_9kR3WTr26646CP2pu"></a>Date of report (<a id="z_9kMHG5YVt48868ER4rw"></a>Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_c14f77e49a114697b8456846f788c7bc" contextRef="c20260519to20260519" format="ixt:date-monthname-day-year-en">May 19, 2026</ix:nonNumeric></div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/> </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 24pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_3db9bfd7a3d949c8b3ced214017fb435" contextRef="c20260519to20260519">VIAVI SOLUTIONS INC.</ix:nonNumeric><br/>
      </div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(Exact name of <a id="z_9kR3WTr26646DeKglyAAsp9"></a>Registrant as specified in its <a id="z_9kMHG5YVt7DA69GbX331y2sq63xC"></a>charter)</div>

      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 33%; vertical-align: bottom; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_817cfa5ed55240f6a9e9cd5122dd57b6" contextRef="c20260519to20260519" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric><br/>
              </div>
            </td>

    <td style="width: 34%; vertical-align: bottom; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_9d7548b001b24bc78d4a069a665e8b73" contextRef="c20260519to20260519">000-22874</ix:nonNumeric><br/>
              </div>
            </td>

    <td style="width: 33%; vertical-align: bottom; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_e934589b8f4d460a911af64b61886bb6" contextRef="c20260519to20260519">94-2579683</ix:nonNumeric><br/>
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 33%; vertical-align: top; white-space: nowrap;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(State or other jurisdiction of incorporation or organization)</div>
            </td>

    <td style="width: 34%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">(Commission file number)</div>
            </td>

    <td style="width: 33%; vertical-align: top; white-space: nowrap;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(I.R.S. Employer Identification Number)</div>
            </td>

  </tr>


</table>
      <div>
        <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"> <br/>
        </div>

        <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_4cc42160245f4a1a838f34c4390e0ccc" contextRef="c20260519to20260519">1445 South Spectrum Blvd</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" id="Fact_2380dc9d9a2d4e5ebb4f7b81876626a6" contextRef="c20260519to20260519">Suite 102</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_ea063b7550de48a491a564166fa8a3c2" contextRef="c20260519to20260519">Chandler</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_89fbec9a53914bfcad0fc8458d92aab9" contextRef="c20260519to20260519" format="ixt-sec:stateprovnameen">Arizona</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_ebaf366464224195baed29bb416d8160" contextRef="c20260519to20260519">85286</ix:nonNumeric></div>

        <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">
          <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">(Address of principal executive offices and <a id="z_9kR3WTr26646EnWtOIqh"></a>Zip Code)</div>

        </div>

      </div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;<span style="font-family: 'Times New Roman'; font-weight: bold;">(<ix:nonNumeric name="dei:CityAreaCode" id="Fact_3e16b0217e4a48daa659ae8ace06988b" contextRef="c20260519to20260519">408</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_4d75192b7f9c437da9561b8660ada95b" contextRef="c20260519to20260519">404-3600</ix:nonNumeric></span></div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(<a id="z_9kMHG5YVt48868FgMin0CCurB"></a>Registrant&#8217;s telephone number, including area code)</div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>

      <div style="text-align: center;">
<div><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span></div>

        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 32%; vertical-align: bottom; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Title of each class</div>
            </td>

    <td style="width: 1.51%; vertical-align: middle; font-size: 10pt; padding-bottom: 2px; text-align: center;">&#160;</td>

    <td style="width: 32%; vertical-align: bottom; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Trading Symbol</div>
            </td>

    <td style="width: 1.51%; vertical-align: middle; font-size: 10pt; padding-bottom: 2px; text-align: center;">&#160;</td>

    <td style="width: 32%; vertical-align: bottom; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Name of the exchange on which registered</div>
            </td>

  </tr>

  <tr>

    <td style="width: 32%; vertical-align: bottom; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_f76c329158f74765845ef50355b57f05" contextRef="c20260519to20260519">Common Stock, par value of $0.001 per share</ix:nonNumeric><br/>
              </div>
            </td>

    <td style="width: 1.51%; vertical-align: middle; font-size: 10pt;">&#160;</td>

    <td style="width: 32%; vertical-align: bottom; font-size: 10pt; text-align: center;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_d04cf18cc1bc450ea3e63457e7941aa9" contextRef="c20260519to20260519">VIAV</ix:nonNumeric><br/>
            </td>

    <td style="width: 1.51%; vertical-align: middle; font-size: 10pt;">&#160;</td>

    <td style="width: 32%; vertical-align: bottom; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_f6f58141b59d430d8ea8244082c598e2" contextRef="c20260519to20260519" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric><br/>
              </div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Check the appropriate box below if the <a id="z_9kR3WTr26646FUI10Ie"></a>Form 8-K filing is intended to simultaneously satisfy the filing obligation of
        the registrant under any of the following provisions:</div>

      <a id="z_9kMHG5YVt3DE69EfNevB034q1YD3"></a>
<table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 18pt; vertical-align: top;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_3222d84464664201a33c80a84e36b7ee" contextRef="c20260519to20260519" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 18pt; vertical-align: top;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_7d06e729d4624a39be906b769e216b76" contextRef="c20260519to20260519" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
            </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 18pt; vertical-align: top;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_1a9d6bf6eedc4f0fac757e8b925b744e" contextRef="c20260519to20260519" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
            </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 18pt; vertical-align: top;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_ab8d514c8a114f63a66540863ad14283" contextRef="c20260519to20260519" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant is an emerging growth <a id="z_9kMHG5YVt46669CNHy0poD"></a>company as defined in as defined in Rule 405
        of the <a id="z_9kMIH5YVt3DE69EfNevB034q1YD3"></a>Securities Act of 1933 (17 CFR &#167;230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2).</div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Emerging growth <a id="z_9kMIH5YVt46669CNHy0poD"></a>company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_abee6deda7cc40cbb25a382d1f496b8a" contextRef="c20260519to20260519" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">If an emerging growth <a id="z_9kMJI5YVt46669CNHy0poD"></a>company, indicate by check mark if the registrant has elected not to use the extended
        transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <a id="z_9kR3WTr5B847D"></a>&#9744;</div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-family: 'Times New Roman';"> <br/>
        </span></div>

      <div>
        <div style="text-align: left;">
<div><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span></div>

          <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/></div>

        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

        </div>

      </div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 72pt; vertical-align: top; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ITEM&#8201;8.01</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Other Events.</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Underwriting Agreement</div>

      <div style="font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">On May 19, 2026, Viavi Solutions Inc. (the &#8220;<a id="z_9kR3WTr244458LFwynmB"></a><a id="z_9kR3WTr24447ALFwynmB"></a>Company&#8221;) entered into an underwriting agreement
        (the &#8220;Underwriting Agreement&#8221;) with Stifel, Nicolaus &amp; Company, Incorporated (&#8220;Stifel&#8221;) and Needham &amp; Company, LLC (&#8220;Needham &amp; Company&#8221;), as representatives of the several underwriters named therein (collectively, the &#8220;Underwriters&#8221;),
        relating to the public offering, issuance and sale (the &#8220;<a id="z_9kR3WTr244459YIggtyvu"></a>Offering&#8221;) of 11,111,111 shares of the Company&#8217;s common stock, par value $0.001 per share (&#8220;<a id="z_9kR3WTr1BC45BOFwvy0fg9tq"></a><a id="z_9kR3WTr1BC47BMFwvy0fg9tq"></a>Common Stock&#8221;), at a public offering price of $45.00 per share of Common Stock. Under the terms of the Underwriting Agreement, the Company also granted the Underwriters an option exercisable for 30 days from
        the date of the Underwriting Agreement to purchase up to an additional 1,666,666 shares of Common Stock at the public <a id="z_9kMHG5YVt46667BaKiiv0xw"></a>offering price, less underwriting discounts and commissions (the &#8220;Option&#8221;), which the
        Underwriters exercised in full on May 20, 2026.</div>

      <div style="font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The net proceeds to the Company from the Offering are approximately $557.2 million, which includes the proceeds from the exercise of the Option, after deducting
        underwriting discounts and commissions and estimated <a id="z_9kMIH5YVt46667BaKiiv0xw"></a>offering expenses payable by the Company. The Company currently intends to use the net proceeds from the Offering to repay the $450 million aggregate
        principal amount of the Company&#8217;s 7-year term loan facility entered into in March 2025. Any excess net proceeds are expected to be used for working capital or for other general corporate purposes.</div>

      <div style="font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The Underwriting Agreement contains customary representations, warranties and agreements by the Company, customary conditions to closing, indemnification obligations of
        the Company and the Underwriters, including for liabilities under the Securities Act of 1933, as amended, other obligations of the parties and termination provisions. The representations, warranties and covenants contained in the Underwriting
        Agreement were made only for the purposes of such agreement and as of specific dates, were solely for the benefit of the parties to such agreement and may be subject to limitations agreed upon by the contracting parties, including being qualified
        by confidential disclosures exchanged between the parties in connection with the execution of the Underwriting Agreement. In addition, pursuant to the terms of the Underwriting Agreement, the Company and its executive officers and directors have
        entered into customary &#8220;lock-up&#8221; arrangements with Stifel and Needham &amp; Company, which generally prohibit the sale, transfer or other disposition of securities of the Company for a 60-day period, subject to certain exceptions. The Underwriting
        Agreement is filed as Exhibit 1.1 hereto and is incorporated by reference herein, and the description of the material terms of the Underwriting Agreement does not purport to be complete and is qualified in its entirety by reference to such exhibit.</div>

      <div style="font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The Offering was made pursuant to an automatic shelf registration statement on <a id="z_9kR3WTr26645EUI10"></a>Form S-3 (File No. 333-289490), which was filed with the
        U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) on August 11, 2025 and was automatically effective upon filing. A final prospectus supplement dated May 19, 2026 relating to and describing the terms of the Offering was filed with the SEC on May
        20, 2026. A copy of the opinion of Gibson, Dunn &amp; Crutcher LLP relating to the validity of the shares of Common Stock issued in the Offering is filed herewith as Exhibit 5.1.</div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 72pt; vertical-align: top; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ITEM&#8201;9.01</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Financial Statements and Exhibits.</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(d)</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman'; font-weight: bold;">Exhibits</div>
            </td>

  </tr>


</table>
      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <a id="z_9kR3WTr26646AZEchKO6yxug07A7QH45SV85"></a><a id="z_9kR3WTr266468QKuqtqb3y9"></a>
<table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 5.42%; vertical-align: bottom; font-size: 10pt; white-space: nowrap;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Exhibit</div>
            </td>

    <td style="width: 94.52%; vertical-align: bottom; font-size: 10pt; white-space: nowrap;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Description</div>
            </td>

  </tr>

  <tr>

    <td style="width: 5.42%; vertical-align: middle; font-size: 10pt;"><br/>
            </td>

    <td style="width: 94.58%; vertical-align: middle; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 5.42%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="ef20074430_ex1-1.htm">1.1</a></div>
            </td>

    <td style="width: 94.52%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">Underwriting Agreement, dated as of May 19, 2026, by and among Viavi Solutions Inc., Stifel, Nicolaus &amp; Company, Incorporated and Needham &amp; Company, LLC.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 5.42%; vertical-align: middle; font-size: 10pt;">&#160;</td>

    <td style="width: 94.58%; vertical-align: middle; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 5.42%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="ef20074430_ex5-1.htm">5.1</a></div>
            </td>

    <td style="width: 94.52%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">Opinion of Gibson, Dunn &amp; Crutcher LLP.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 5.42%; vertical-align: middle; font-size: 10pt;">&#160;</td>

    <td style="width: 94.58%; vertical-align: middle; font-size: 10pt;"><br/>
            </td>

  </tr>

  <tr>

    <td style="width: 5.42%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="ef20074430_ex5-1.htm">23.1</a></div>
            </td>

    <td style="width: 94.52%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">Consent of Gibson, Dunn &amp; Crutcher LLP (contained in Exhibit 5.1).</div>
            </td>

  </tr>

  <tr>

    <td style="width: 5.42%; vertical-align: middle; font-size: 10pt;">&#160;</td>

    <td style="width: 94.58%; vertical-align: middle; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 5.42%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255); white-space: nowrap;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">104</div>
            </td>

    <td style="width: 94.52%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Cover Page Interactive Data File (embedded within the Inline
                XBRL document)</div>
            </td>

  </tr>


</table>
      <div> <br/>
      </div>

      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SIGNATURE</div>

      <div style="font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the <a id="z_9kR3WTr26646BcKglyAAsp9"></a>Registrant has duly caused this report to be
        signed on its behalf by the undersigned hereunto duly authorized.</div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <a id="z_9kMHG5YVt48867FT4rw"></a>
<table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 15%; vertical-align: bottom; font-size: 10pt;"><br/>
            </td>

    <td style="vertical-align: bottom; font-size: 10pt;" colspan="2">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">VIAVI SOLUTIONS INC.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 15%; vertical-align: middle; font-size: 10pt;"><br/>
            </td>

    <td style="width: 3%; vertical-align: middle; font-size: 10pt;"><br/>
            </td>

    <td style="width: 82%; vertical-align: middle; font-size: 10pt;"><br/>
            </td>

  </tr>

  <tr>

    <td style="width: 15%; vertical-align: bottom; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';"><span style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Date: May </span>21<span style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">, 2026</span></div>
            </td>

    <td style="width: 3%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">By:</div>
            </td>

    <td style="width: 82%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div>
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">/s/ Ilan Daskal</div>
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 15%; vertical-align: bottom; font-size: 10pt;"><br/>
            </td>

    <td style="width: 3%; vertical-align: bottom; font-size: 10pt;">&#160;</td>

    <td style="width: 82%; vertical-align: bottom; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Ilan Daskal</div>
            </td>

  </tr>

  <tr>

    <td style="width: 15%; vertical-align: bottom; font-size: 10pt;"><br/>
            </td>

    <td style="width: 3%; vertical-align: bottom; font-size: 10pt;">&#160;</td>

    <td style="width: 82%; vertical-align: bottom;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Chief Financial Officer</div>
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">(Duly Authorized Officer and Principal Financial and Accounting Officer)</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="font-size: 10pt;">
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/> </div>

    </div>

  </div>

  <div><span style="font-size: 10pt;"> </span></div>

</div>
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ef20074430_ex1-1.htm
<DESCRIPTION>EXHIBIT 1.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 26.3.2.5342
         Copyright 1995 - 2026 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <font style="font-size: 10pt;"> </font>
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div style="font-size: 10pt; text-align: right;"><font style="font-weight: bold;">Exhibit 1.1</font><br>
    </div>
    <div> <font style="font-size: 10pt;"><br>
      </font></div>
    <div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">11,111,111 Shares</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-variant: small-caps;">VIAVI SOLUTIONS INC.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Common Stock</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><u>UNDERWRITING AGREEMENT</u></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: right; text-indent: 288pt; font-family: 'Times New Roman'; font-size: 10pt;">&#160;May 19, 2026</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">STIFEL, NICOLAUS &amp; COMPANY, INCORPORATED</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">NEEDHAM &amp; COMPANY, LLC</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">As representatives of the several Underwriters</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">named in Schedule I hereto</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">c/o Stifel, Nicolaus &amp; Company, Incorporated</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 36pt;">1201 Wills Street, 6<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> Floor</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 36pt;">Baltimore, MD 21231</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">c/o Needham &amp; Company, LLC</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 36pt;">250 Park Avenue, 10<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> Floor</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 36pt;">New York, NY 10177</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Ladies and Gentlemen:</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Viavi Solutions Inc., a Delaware corporation (the &#8220;Company&#8221;), proposes to issue and sell to the several underwriters named in Schedule I hereto (the
        &#8220;Underwriters&#8221;) for whom you are acting as representatives (the &#8220;Representatives&#8221;) an aggregate of 11,111,111 shares (the &#8220;Firm Shares&#8221;) of the common stock, par value $0.001 per share, of the Company (&#8220;Common Stock&#8221;).&#160; The Company also proposes to
        grant to the several Underwriters, an option to purchase up to an additional 1,666,666 shares of Common Stock (the &#8220;Option Shares&#8221;).&#160; The Firm Shares and the Option Shares are hereinafter referred to collectively as the &#8220;Shares.&#8221;</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Company confirms as follows its agreements with the Representatives and the several other Underwriters.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">1.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">The Company represents and warrants
            to, and agrees with, each of the Underwriters that, as of the date hereof and as of the Closing Date (as defined below) and each Option Closing Date (as defined below), if any:</font></font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';"><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%%%-->
      <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The Company has
            prepared and filed with the Securities and Exchange Commission (the &#8220;Commission&#8221;) an automatic shelf registration statement on Form S-3 (File No. 333-289490) covering the public offering and sale of certain securities, including the Shares,
            under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), which automatic shelf registration statement became effective upon filing under Rule 462(e) of the rules and regulations of the Commission (&#8220;Rules and Regulations&#8221;) under the
            Securities Act. Such registration statement, as of any time, means such registration statement as amended by any post-effective amendments thereto at such time, and including the exhibits and any schedules thereto at such time, the documents
            incorporated or deemed to be incorporated by reference therein at such time pursuant to Item 12 of Form S-3 under the Securities Act and the documents otherwise deemed to be a part thereof as of such time pursuant to Rule 430B of the Rules and
            Regulations (&#8220;Rule 430B&#8221;), is referred to herein as the &#8220;Registration Statement;&#8221; provided, however, that the &#8220;Registration Statement&#8221; without reference to a time means such registration statement as amended by any post-effective amendments
            thereto as of the time of the first contract of sale for the Shares, which time shall be considered the &#8220;new effective date&#8221; of such registration statement with respect to the Shares within the meaning of paragraph (f)(2) of Rule 430B,
            including the exhibits and schedules thereto as of such time, the documents incorporated or deemed incorporated by reference therein at such time pursuant to Item 12 of Form S-3 under the Securities Act and the documents otherwise deemed to be
            a part thereof as of such time pursuant to Rule 430B. Each preliminary prospectus used in connection with the offering of the Shares, including the documents incorporated or deemed to be incorporated by reference therein pursuant to Item 12 of
            Form S-3 under the Securities Act, are collectively referred to herein as a &#8220;Preliminary Prospectus.&#8221; Promptly after execution and delivery of this Agreement, the Company will prepare and file a final prospectus relating to the Shares in
            accordance with the provisions of Rule 424(b) under the Rules and Regulations (&#8220;Rule 424(b)&#8221;). The final prospectus, in the form first furnished or made available to the Underwriters for use in connection with the offering of the Shares,
            including the documents incorporated or deemed to be incorporated by reference therein pursuant to Item 12 of Form S-3 under the Securities Act, are collectively referred to herein as the &#8220;Prospectus.&#8221; For purposes of this Agreement, all
            references to the Registration Statement, any Preliminary Prospectus, the Prospectus or any amendment or supplement to any of the foregoing shall be deemed to include the copy filed with the Commission pursuant to its Electronic Data Gathering,
            Analysis and Retrieval system (or any successor system) (&#8220;EDGAR&#8221;).</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">As used in this Agreement:</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;Applicable Time&#8221; means 8:00 P.M. (Eastern time) on the date of this Agreement or such other time as agreed by the Company and the Representative;</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;Testing-the-Waters Communication&#8221; means any oral or written communication with potential investors undertaken in reliance on Rule 163B under the
        Securities Act;</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">2</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;Written Testing-the-Waters Communication&#8221; means any Testing-the-Waters Communication that is a written communication within the meaning of Rule 405
        under the Securities Act; and</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;Issuer Free Writing Prospectus&#8221; means any &#8220;issuer free writing prospectus,&#8221; as defined in Rule 433 under the Securities Act relating to the Shares.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">All references in this Agreement to financial statements and schedules and other information that is &#8220;described,&#8221; &#8220;contained,&#8221; &#8220;included&#8221; or
        &#8220;stated&#8221; in the Registration Statement, any Preliminary Prospectus or the Prospectus (or other references of like import) shall be deemed to mean and include all such financial statements and schedules and other information that is incorporated by
        reference in or otherwise deemed by the Securities Act to be a part of or included in the Registration Statement, any Preliminary Prospectus or the Prospectus, as the case may be. All references in this Agreement to amendments or supplements to the
        Registration Statement, any Preliminary Prospectus, or the Prospectus shall be deemed to mean and include the subsequent filing of any document under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;) and which is deemed to be
        incorporated by reference therein or otherwise deemed by the Rules and Regulations to be a part thereof; the documents incorporated or deemed to be incorporated by reference in the Registration Statement, any Preliminary Prospectus and the
        Prospectus, when they became effective or at the time they were or hereafter are filed with the Commission, complied and will comply in all material respects with the requirements of the Exchange Act.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">(1) Each of the Registration
            Statement and any post-effective amendment thereto, at the time of its effectiveness, each deemed effective date with respect to the Underwriters pursuant to Rule 430B of the Rules and Regulations, at the Applicable Time (as defined herein),
            and at the Closing Date (as defined herein) (and, if any Option Shares are purchased, at each Option Closing Date (as defined herein)), complied and will comply in all material respects with the requirements of the Securities Act, the Rules and
            Regulations and the Exchange Act, and did not and will not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading; (2) neither the
            Prospectus nor any amendment or supplement thereto, as of its date, at the time of any filing with the Commission pursuant to Rule 424(b), at the Closing Date (as defined herein) (and, if any Option Shares are purchased, at each Option Closing
            Date (as defined herein)), included, includes or will include an untrue statement of a material fact or omitted, omits or will omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances
            under which they were made, not misleading; (3) the documents incorporated or deemed to be incorporated by reference in the Registration Statement, the Pricing Disclosure Package (as defined below) and the Prospectus, at the time the
            Registration Statement became effective or when such documents incorporated by reference were filed with the Commission, as the case may be, when read together with the other information in the Registration Statement, the Pricing Disclosure
            Package or the Prospectus, as the case may be, did not and will not include an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading; and
            (4) each Preliminary Prospectus, the Prospectus and any amendment or supplement thereto, at the time each was filed with the Commission, and, in each case, at the Applicable Time and at the Closing Date (and, if any Option Shares are purchased,
            at each Option Closing Date), complied and will comply in all material respects with the requirements of the Rules and Regulations and each Preliminary Prospectus and the Prospectus delivered to the Underwriters for use in connection with this
            offering was identical to the electronically transmitted copies thereof filed with the Commission pursuant to EDGAR, except to the extent permitted by Regulation S-T; provided that the representations and warranties in clauses (1), (2) and (3)
            above shall not apply to statements in or omissions from any Registration Statement, Prospectus or documents incorporated or deemed to be incorporated in the Registration Statement, the Pricing Disclosure Package or the Prospectus made in
            reliance upon and in conformity with information furnished to the Company in writing by any Underwriter through the Representatives expressly for use therein, it being understood and agreed that the only such information provided by any
            Underwriter is that described as such in Section 9(b) hereof;</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">3</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The Pricing Disclosure Package, as
            of the Applicable Time, complied in all material respects with the requirements of the Securities Act and the Rules and Regulations and did not include any untrue statement of a material fact or omit to state any material fact necessary in
            order to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided that the preceding sentence shall not apply to statements in or omissions from the Pricing Disclosure Package made in
            reliance upon and in conformity with information furnished to the Company in writing by any Underwriter through the Representatives expressly for use therein, it being understood and agreed that the only such information provided by any
            Underwriter is that described as such in Section 9(b) hereof. As of the Applicable Time, neither (1) any Issuer Free Writing Prospectus, Written Testing-the-Waters Communications and other documents listed in Schedule II hereto issued at or
            prior to the Applicable Time, and the most recent Preliminary Prospectus (including any documents incorporated or deemed to be incorporated by reference therein) immediately prior to the Applicable Time, all considered together with the other
            information set forth on Schedule III (collectively, the &#8220;Pricing Disclosure Package&#8221;), nor (2) any individual Issuer Free Writing Prospectus and/or Written Testing-the-Waters Communication, when considered together with the Pricing Disclosure
            Package, included as of the Applicable Time, any untrue statement of a material fact or omitted as of the Applicable Time to state any material fact necessary in order to make the statements therein, in the light of the circumstances under
            which they were made, not misleading; provided that the representations and warranties in clauses (1) and (2) above shall not apply to statements in or omissions from any Preliminary Prospectus or any Issuer Free Writing Prospectus or Written
            Testing-the-Waters Communication made in reliance upon and in conformity with information furnished to the Company in writing by any Underwriter through the Representatives expressly for use therein, it being understood and agreed that the only
            such information provided by any Underwriter is that described as such in Section 9(b) hereof;</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">4</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iv)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The Company meets the requirements
            for use of Form S-3 under the Securities Act. The Registration Statement is an &#8220;automatic shelf registration statement&#8221; (as defined in Rule 405) and the Shares have been and remain eligible for registration by the Company on such automatic
            shelf registration statement. The Company has not received from the Commission any notice pursuant to Rule 401(g)(2) of the Rules and Regulations objecting to the use of the automatic shelf registration statement form. The Registration
            Statement became effective upon filing under Rule 462(e) of the Rules and Regulations on August 11, 2025, and any post-effective amendment thereto becomes effective upon filing under Rule 462(e) of the Rules and Regulations. No stop order
            preventing or suspending the use of any Preliminary Prospectus, the Prospectus or suspending the effectiveness of the Registration Statement or any post-effective amendment thereto has been issued and no proceedings for that purpose have been
            initiated or threatened by the Commission; at the time of filing the Registration Statement, at the earliest time thereafter that the Company or another offering participant made a bona fide offer (within the meaning of Rule 164(h)(2) of the
            Rules and Regulations) of the Shares and at the date hereof, <a name="z_cp_change_298"></a>the Company was not and is not an &#8220;ineligible issuer,&#8221; as defined under Rule 405 under the Securities Act without taking account of any determination by
            the Commission pursuant to Rule 405 that it is not necessary that the company be considered an &#8220;ineligible issuer&#8221;, and as of the date hereof, the conditions for use of Form S-3, set forth in the General Instructions thereto, were and have been
            satisfied;<a name="z_cp_change_299"></a></font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(v)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Each Issuer Free Writing Prospectus,
            as of its issue date and at the Closing Date (as defined herein) (and, if any Option Shares are purchased, at each Option Closing Date (as defined herein)), did not, does not and will not include any information that conflicted, conflicts or
            will conflict with the information contained in the Registration Statement or the Prospectus, including any document incorporated or deemed to be incorporated by reference therein; provided that the foregoing sentence shall not apply to
            statements in or omissions from any Issuer Free Writing Prospectus or Written Testing-the-Waters Communication made in reliance upon and in conformity with information furnished to the Company in writing by any Underwriter through the
            Representatives expressly for use therein, it being understood and agreed that the only such information provided by any Underwriter is that described as such in Section 9(b) hereof. Any offer that is a written communication relating to the
            Shares made prior to the initial filing of the Registration Statement by the Company or any person acting on its behalf (within the meaning, for this paragraph only, of Rule 163(c) of the Rules and Regulations) that is required to be filed with
            the Commission has been filed with the Commission in accordance with the exemption provided by Rule 163 and otherwise complied with the requirements of Rule 163, including without limitation the legending requirement, to qualify such offer for
            the exemption from Section 5(c) of the Securities Act provided by Rule 163;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(vi)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The Common Stock is included or
            approved for listing on the Nasdaq Global Select Market and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from
            the Nasdaq Global Select Market nor has the Company received any notification that the Commission or the Nasdaq Global Select Market is contemplating terminating such registration or listing; the Company has complied in all material respects
            with the applicable requirements of the Nasdaq Global Select Market for maintenance of inclusion of the Common Stock thereon; the Company has submitted a listing of additional shares notification form to The Nasdaq Stock Market LLC to include
            the Shares on the Nasdaq Global Select Market; except as previously disclosed to counsel for the Underwriters or as set forth in the Pricing Disclosure Package and the Prospectus, there are no affiliations with members of FINRA among the
            Company&#8217;s officers or directors or, to the knowledge of the Company, any five percent or greater stockholders of the Company, any beneficial owner of the Company&#8217;s capital stock or subordinated debt who, together with their associated persons
            and affiliates, hold in the aggregate 10% or more of such capital stock or subordinated debt, or any beneficial owner of the Company&#8217;s unregistered equity securities that were acquired during the 180-day period immediately preceding the initial
            filing date of the Registration Statement through the offering of the Shares;</font></font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">5</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(vii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The Company has been duly
            incorporated and is validly existing as a corporation in good standing under the laws of the State of Delaware, with power and authority (corporate and other) to own, lease and operate its properties and conduct its business as described in the
            Registration Statement, the Pricing Disclosure Package, and the Prospectus and to enter into and perform its obligations under this Agreement, and (i) has been duly qualified as a foreign corporation for the transaction of business and is in
            good standing (where such concept exists) under the laws of each other jurisdiction in which it owns or leases properties, or (ii) conducts no business so as to require such qualification or is subject to no material liability or disability by
            reason of the failure to be so qualified or be in good standing in any such jurisdiction;</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(viii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Each subsidiary of the Company (each
            a &#8220;Subsidiary&#8221;) has been duly incorporated (or organized) and is validly existing as a corporation (or other organization) in good standing (where such concept exists) under the laws of the jurisdiction of its incorporation (or organization),
            with power and authority to own, lease and operate its properties and conduct its business as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, and (i) has been duly qualified as a foreign corporation
            (or other organization) for the transaction of business and is in good standing (where such concept exists) under the laws of each other jurisdiction in which it owns or leases properties or conducts any business so as to require such
            qualification, or (ii) is subject to no material liability or disability by reason of the failure to be so qualified or be in good standing in any such jurisdiction; all of the issued and outstanding capital stock (or other ownership interests)
            of each Subsidiary has been duly and validly authorized and issued, is fully paid and non-assessable and is owned by the Company, directly or through Subsidiaries, free and clear of any security interest, mortgage, pledge, lien, encumbrance,
            claim or equity, other than pledges of equity securities of Subsidiaries granted pursuant to that certain Credit Agreement, dated as of December 30, 2021, among the Company, Wells Fargo Bank, National Association, as agent and other parties
            party thereto;</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ix)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The Company has an authorized
            capitalization as set forth in the Registration Statement, Pricing Disclosure Package and the Prospectus, and all of the issued and outstanding shares of capital stock of the Company have been duly and validly authorized and issued, are fully
            paid and non-assessable and conform to the descriptions thereof contained in the Registration Statement, Pricing Disclosure Package and the Prospectus; and none of the issued and outstanding shares of capital stock of the Company are subject to
            any preemptive or similar rights. Except as disclosed in the Registration Statement, Pricing Disclosure Package or the Prospectus, there is no outstanding option, warrant or other right calling for the issuance of, and there is no commitment,
            plan or arrangement to issue, any share of capital stock of the Company or any of its Subsidiaries or any security convertible into, or exercisable or exchangeable for, such stock. The exercise price of each option to acquire Common Stock
            (each, a &#8220;Company Stock Option&#8221;) is no less than the fair market value of a share of Common Stock as determined on the date of grant of such Company Stock Option. All grants of Company Stock Options and restricted stock units were validly
            issued and duly authorized and approved by the Board of Directors of the Company (or committees thereof) in compliance with all applicable laws and the terms of the plan under which such Company Stock Options and restricted stock units were
            issued and were recorded on the Company&#8217;s financial statements in accordance with U.S. GAAP (as defined herein), and no such grants involved any &#8220;back dating,&#8221; &#8220;forward dating&#8221;, &#8220;spring loading&#8221; or similar practices with respect to the
            effective date of grant;</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">6</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(x)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman';">The Shares have been duly and
            validly authorized and, when issued and delivered to and paid for by the Underwriters in accordance with the terms of this Agreement, will be duly and validly issued and fully paid and non-assessable and will conform in all material respects to
            the descriptions thereof contained in the Registration Statement, Pricing Disclosure Package and the Prospectus; and the issuance of the Shares is not subject to any preemptive or similar rights that have not been complied with or otherwise
            effectively waived;</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(xi)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">This Agreement has been duly
            authorized, executed and delivered by the Company;</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(xii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The issue and sale of the Shares,
            the execution of this Agreement by the Company and the compliance by the Company with this Agreement and the consummation of the transactions herein contemplated will not (i) conflict with or result in a breach or violation of any of the terms
            or provisions of, or constitute a default under, any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which the Company or any of the Subsidiaries is a party or by which the Company or any of the
            Subsidiaries is bound or to which any of the property or assets of the Company or any of the Subsidiaries is subject, (ii) result in any violation of the provisions of the certificate of incorporation or bylaws (or similar organization
            documents) of the Company or any of the Subsidiaries or (iii) result in any violation of any statute or any order, rule or regulation of any court or governmental agency or body having jurisdiction over the Company or any of the Subsidiaries or
            any of their properties, except in the case of (i) and (iii) for such violations that would not, individually or in the aggregate, be expected to have a Material Adverse Effect; and no consent, approval, authorization, order, registration or
            qualification of or with any such court or governmental agency or body is required for the issue and sale of the Shares or the consummation by the Company of the transactions contemplated by this Agreement, except for the registration under the
            Securities Act of the issuance of the Shares and such consents, approvals, authorizations, registrations or qualifications as may be required under state securities or Blue Sky laws in connection with the purchase and distribution of the Shares
            by the Underwriters. &#8220;Material Adverse Effect&#8221; means any material adverse change, or any development involving a prospective material adverse change, in or affecting the general affairs, management, financial position, stockholders&#8217; equity,
            prospects or results of operations of the Company and the Subsidiaries taken as a whole;</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(xiii)</font><font style="font-size: 10pt;">&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman';">(1) At the original effectiveness
            of the Registration Statement, (2) at the time of the most recent amendment thereto for the purposes of complying with Section 10(a)(3) of the Securities Act (whether such amendment was by post-effective amendment, incorporated report filed
            pursuant to Section 13 or 15(d) of the Exchange Act or form of prospectus), (3) at the time the Company or any person acting on its behalf (within the meaning of Rule 163(c) of the Rules and Regulations) made any offer relating to the Shares in
            reliance on the exemption of Rule 163 of the Rules and Regulations (&#8220;Rule 163&#8221;) and (4) as of the Applicable Time, the Company was and is a &#8220;well-known seasoned issuer&#8221; as defined in Rule 405 of the Rules and Regulations (&#8220;Rule 405&#8221;);</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">7</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(xiv)</font><font style="font-size: 10pt;">&#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman';">PricewaterhouseCoopers LLP, which has
            certified certain financial statements of the Company and the Subsidiaries and delivered its opinion with respect to the audited financial statements and schedules included in the Registration Statement, the Pricing Disclosure Package, and the
            Prospectus, is an independent registered public accounting firm as required by the Securities Act and the Rules and Regulations.&#160; The financial statements, together with related schedules and notes included in the Registration Statement, the
            Pricing Disclosure Package, and the Prospectus, comply in all material respects with the requirements of the Securities Act and present fairly in all material respects the consolidated financial position, results of operations and changes in
            financial position of the Company and the Subsidiaries on the basis stated in the Registration Statement, the Pricing Disclosure Package and the Prospectus at the respective dates or for the respective periods to which they apply; such
            statements and related schedules and notes have been prepared in accordance with generally accepted accounting principles as applied in the United States (&#8220;U.S. GAAP&#8221;) consistently applied throughout the periods involved, except as disclosed in
            the Registration Statement, the Pricing Disclosure Package and the Prospectus.&#160; All information contained or incorporated by reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus regarding &#8220;non-GAAP
            financial measures&#8221; (as defined in Regulation G) complies with Regulation G and Item 10 of Regulation S-K, to the extent applicable. The interactive data in eXtensible Business Reporting Language included or incorporated by reference in the
            Registration Statement, if any, fairly presents the information called for in all material respects and has been prepared in accordance with the Commission&#8217;s rules and guidelines applicable thereto;</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(xv)</font><font style="font-size: 10pt;">&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman';">Neither the Company nor any
            Subsidiary has sustained since the date of the latest audited financial statements included or incorporated by reference in the Pricing Disclosure Package any material loss or interference with its business from fire, explosion, flood or other
            calamity, whether or not covered by insurance, or from any labor dispute or court or governmental action, order or decree, otherwise than as set forth or contemplated in the Pricing Disclosure Package; and, since the respective dates as of
            which information is given in the Registration Statement, the Pricing Disclosure Package, and the Prospectus, (1) there has not been any change in the capital stock (other than as a result of (i) the grant, vesting or exercise of stock options
            or other equity incentives pursuant to the Company&#8217;s equity incentive plans, or (ii) the repurchase of shares of capital stock pursuant to agreements providing for an option to repurchase or a right of first refusal on behalf of the Company, in
            each case as such (A) equity incentive plans, (B) outstanding equity incentives and (C) agreements are described in the Pricing Disclosure Package) or any change in long-term debt of the Company or any of the Subsidiaries (other than borrowings
            under the Company&#8217;s credit facilities described in the Pricing Disclosure Package), (2) there has not been any Material Adverse Effect, (3) there have been no transactions entered into by, and no obligations or liabilities, contingent or
            otherwise, incurred by the Company or any of its Subsidiaries, not in the ordinary course of business, which are material to the Company and its Subsidiaries, considered as one enterprise or (4) there has been no dividend or distribution of any
            kind declared, paid or made by the Company on any class of its capital stock, in each case, otherwise than as set forth or contemplated in the Pricing Disclosure Package;</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">8</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(xvi)</font><font style="font-size: 10pt;">&#160;&#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman';">Neither the Company nor any of its
            Subsidiaries is (1) in violation of its certificate of incorporation or bylaws (or other organization documents), (2) in violation of any law, ordinance, administrative or governmental rule or regulation applicable to the Company or any of its
            Subsidiaries, (3) in violation of any decree of any court or governmental agency or body having jurisdiction over the Company or any of its Subsidiaries, (4) in default in the performance of any obligation, agreement or condition contained in
            any bond, debenture, note or any other evidence of indebtedness or in any agreement, indenture, lease or other instrument to which the Company or any of its Subsidiaries is a party or by which any of them or any of their respective properties
            may be bound, except, in the case of clauses (2), (3) and (4), where any such violation or default, individually or in the aggregate, would not have a Material Adverse Effect;</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(xvii)</font><font style="font-size: 10pt;">&#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman';">Except as disclosed in the
            Registration Statement, the Pricing Disclosure Package and the Prospectus, the Company and its Subsidiaries do not own any fee interest in real property that is material to its business. The Company and each Subsidiary has valid title to all
            personal property owned by it that is material to its business, in each case free and clear of all liens, encumbrances and defects except such as are described in the Pricing Disclosure Package and the Prospectus or such as do not materially
            affect the value of such property and do not materially interfere with the use made and proposed to be made of such property by the Company or any Subsidiary; and any real property and buildings held under lease by the Company or any Subsidiary
            are held under valid, subsisting and enforceable leases, assuming the compliance with such leases of the counterparties thereto, with such exceptions as are not material and do not materially interfere with the use made and proposed to be made
            of such property and buildings by the Company or any Subsidiary;</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(xviii)</font><font style="font-size: 10pt;"> &#160; &#160; <font style="font-family: 'Times New Roman';">Other than as set forth in the
            Pricing Disclosure Package and the Prospectus, there are no legal or governmental proceedings pending to which the Company or any of its Subsidiaries is a party or of which any property of the Company or any of its Subsidiaries is the subject
            which, if determined adversely to the Company or the Subsidiary, individually or in the aggregate, would have or may reasonably be expected to have a Material Adverse Effect, or would prevent or impair the consummation of the transactions
            contemplated by this Agreement, or which are required to be described in the Registration Statement, the Pricing Disclosure Package or the Prospectus; and, to the Company&#8217;s knowledge, no such proceedings are threatened or contemplated by
            governmental authorities or by others;</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(xix)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The Company and its Subsidiaries
            possess and are in compliance with all permits, licenses, approvals, consents and other authorizations (collectively, &#8220;Permits&#8221;) issued by the appropriate federal, state, local or foreign regulatory agencies or bodies necessary to conduct the
            businesses now operated by them, and all of the Permits are valid and in full force and effect, except, in each case, where the failure to obtain, possess or be in compliance with such Permits, individually or in the aggregate, would not have a
            Material Adverse Effect;</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">9</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(xx)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';">(1)</font>&#160;&#160;&#160;&#160;&#160; The Company and the Subsidiaries own or possess, or can acquire on reasonable terms, adequate rights to use all inventions, copyrights, know-how (including trade secrets and other unpatented and/or unpatentable
            proprietary or confidential information, systems or procedures), trademarks, service marks and trade names, patents and patent rights (collectively &#8220;Intellectual Property&#8221;) that are material to carrying on their businesses as described in the
            Pricing Disclosure Package (the &#8220;Company Intellectual Property&#8221;), and there is no pending or, to the Company&#8217;s knowledge, threatened action, suit, proceeding or claim by others (a) challenging the validity, enforceability or scope of any
            Company Intellectual Property that is owned by the Company or (b) challenging the Company&#8217;s rights or any of its Subsidiaries&#8217; rights in or to any Company Intellectual Property that is licensed to the Company or any Subsidiary by a third party,
            and neither the Company nor any of its Subsidiaries is aware of any facts which could form a reasonable basis for any such actions, suits, proceedings or claims; (2) there is no pending or, to the Company&#8217;s knowledge, threatened action, suit,
            proceeding or claim by others that the Company or any of its Subsidiaries infringes or misappropriates any Intellectual Property or other proprietary rights of others and neither the Company nor any of its Subsidiaries is aware of any facts
            which could form a reasonable basis for any such action, suit, proceeding or claim; and (3) to the Company&#8217;s knowledge, none of the Company Intellectual Property has been obtained or is being used by the Company and its Subsidiaries in
            violation of any contractual obligation binding on the Company or its Subsidiaries; in each case of (1), (2), or (3) the occurrence of which, whether individually or in the aggregate, would have a Material Adverse Effect;</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(xxi)</font><font style="font-size: 10pt;">&#160;&#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman';">Neither the Company nor any of its
            Subsidiaries has sent or received any written communication regarding termination of, or intent not to renew, any of the contracts or agreements referred to or described in the Registration Statement, the Pricing Disclosure Package or the
            Prospectus, or referred to or described in, or filed as an exhibit to, the Registration Statement or any document incorporated therein, and no such termination or non-renewal has been threatened by the Company or any of its Subsidiaries or, to
            the Company&#8217;s knowledge, any other party to any such contract or agreement, except as would not reasonably be expected to have a Material Adverse Effect;</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(xxii)</font><font style="font-size: 10pt;">&#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman';">No material labor dispute with the
            employees of the Company or the Subsidiaries exists, or, to the knowledge of the Company, is imminent; to the knowledge of the Company, there is no existing or imminent labor disturbance by the employees of any of its or any Subsidiary&#8217;s
            principal suppliers, manufacturers, customers or contractors, which, individually or in the aggregate, may reasonably be expected to have a Material Adverse Effect;</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(xxiii)</font><font style="font-size: 10pt;">&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The Company and the Subsidiaries are
            insured by insurers of recognized financial responsibility against such losses and risks and in such amounts as are prudent and customary in the businesses in which they are engaged; neither the Company nor any Subsidiary has been refused any
            insurance coverage sought or applied for; and the Company has no reason to believe that either it or any Subsidiary will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from
            similar insurers as may be necessary to continue its business at a cost that would not have a Material Adverse Effect;</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(xxiv)</font><font style="font-size: 10pt;"> &#160; &#160; <font style="font-family: 'Times New Roman';">The Company and each of its
            Subsidiaries have made and keep books, records and accounts, which, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company and its Subsidiaries.&#160; The Company maintains a system of
            internal accounting controls sufficient to provide reasonable assurance that (1) transactions are executed in accordance with management&#8217;s general or specific authorizations; (2) transactions are recorded as necessary to permit preparation of
            financial statements in conformity with generally accepted accounting principles and to maintain accountability for assets; (3) access to assets is permitted only in accordance with management&#8217;s general or specific authorization; (4) the
            recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences; and (5) the interactive data in eXtensible Business Reporting Language included or
            incorporated by reference in the Registration Statement, if any, is in conformity with generally accepted accounting principles and is updated as necessary to comply in all material respects with the requirements of the Securities Act and the
            Commission&#8217;s rules and guidelines applicable thereto and present fairly the consolidated financial position, results of operations and changes in financial position of the Company and the Subsidiaries on the basis stated in the Registration
            Statement at the respective dates or for the respective period to which they apply;</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">10</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(xxv)</font><font style="font-size: 10pt;">&#160;&#160;&#160; &#160; <font style="font-family: 'Times New Roman';">Since the date of the latest audited
            financial statements included or incorporated by reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus, (1) the Company has not been advised of (a) any significant deficiencies in the design or operation of
            internal controls that could adversely affect the ability of the Company and each of its Subsidiaries to record, process, summarize and report financial data, or any material weaknesses in internal controls or (b) any fraud, whether or not
            material, that involves management or other employees who have a significant role in the internal controls of the Company and each of its Subsidiaries; and (2) since that date, there has been no change in the Company&#8217;s internal control over
            financial reporting that has materially and adversely affected, or is reasonably likely to materially and adversely affect, the Company&#8217;s internal control over financial reporting. Except as described in the Registration Statement, the Pricing
            Disclosure Package or the Prospectus, there are no material off-balance sheet arrangements (as defined in Item 303 of Regulation S-K of the Rules and Regulations) that have or are reasonably likely to have a material current or future effect on
            the financial condition, revenues or expenses, changes in financial condition, results of operations, liquidity, capital expenditures or capital resources of the Company and its Subsidiaries taken as a whole;</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(xxvi)</font><font style="font-size: 10pt;">&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The Company maintains disclosure
            controls and procedures (as such term is defined in Rule 13a-15(e) and Rule 15d-15of the Exchange Act) that comply with the requirements of the Exchange Act and that are designed to ensure that information required to be disclosed by the
            Company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission&#8217;s rules and forms, and is accumulated and communicated to the Company&#8217;s
            management, including its principal executive officer or officers and principal financial officer or officers, as appropriate, to allow timely decisions regarding disclosure; such disclosure controls and procedures are effective;</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(xxvii)</font><font style="font-size: 10pt;">&#160;&#160; <font style="font-family: 'Times New Roman';">All United States federal income tax
            returns of the Company and the Subsidiaries required by law to be filed have been filed and all taxes shown by such returns or otherwise assessed, which are due and payable, have been paid, except assessments against which appeals have been or
            will be promptly taken and as to which adequate reserves have been provided. The Company and the Subsidiaries have filed all other tax returns that are required to have been filed by them pursuant to applicable foreign, state, local or other
            law, except insofar as the failure to file such returns, individually or in the aggregate, would not result in a Material Adverse Effect, and have paid all taxes due pursuant to such returns or pursuant to any assessment received by the Company
            or any Subsidiary except for such taxes, if any, as are being contested in good faith and as to which adequate reserves have been provided.&#160; The charges, accruals and reserves on the books of the Company and the Subsidiaries in respect of any
            income and corporation tax liability for any years not finally determined are adequate to meet any assessments or re-assessments for additional income tax for any years not finally determined;</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">11</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(xxviii)</font><font style="font-size: 10pt;">&#160; <font style="font-family: 'Times New Roman';">There are no statutes, regulations,
            documents or contracts of a character required to be described in the Registration Statement, the Pricing Disclosure Package or the Prospectus or to be filed as an exhibit to the Registration Statement which are not described or filed as
            required;</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(xxix)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Neither the Company nor any of the
            Subsidiaries is in violation of any applicable statute, rule, regulation, decision or order of any governmental agency or body or any court, domestic or foreign, relating to the use, production, disposal or release of hazardous or toxic
            substances or relating to the protection or restoration of the environment or human exposure to hazardous or toxic substances (collectively, &#8220;environmental laws&#8221;), owns or operates any real property contaminated with any substance that is
            subject to or would require remedial action under any environmental laws, is liable for any off-site disposal or contamination pursuant to any environmental laws, or is subject to any claim relating to any environmental laws, which violation,
            contamination, remedial action, liability or claim, individually or in the aggregate, would have a Material Adverse Effect; and to the knowledge of the Company, there is no pending investigation which might reasonably be expected to lead to
            such a claim;</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(xxx)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Each employee benefit plan, within
            the meaning of Section 3(3) of the Employee Retirement Income Security Act of 1974, as amended (&#8220;ERISA&#8221;), that is maintained, administered or contributed to by the Company or any Subsidiary for employees or former employees of the Company and
            its affiliates has been maintained in compliance with its terms and the requirements of any applicable statutes, orders, rules and regulations, including but not limited to ERISA and the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;),
            except to the extent that failure to so comply, individually or in the aggregate, would not have a Material Adverse Effect.&#160; No prohibited transaction, within the meaning of Section 406 of ERISA or Section 4975 of the Code has occurred with
            respect to any such plan excluding transactions effected pursuant to a statutory or administrative exemption, except as would not have a Material Adverse Effect;</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(xxxi)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Neither the Company nor any of its
            Subsidiaries, or any director, officer or employee of the foregoing or, to the Company&#8217;s knowledge, any agent or other person acting on behalf of the Company or any of its Subsidiaries, has (1) taken any action in furtherance of an offer,
            payment, promise to pay, or authorization or approval of the payment, giving or receipt of money, property, gifts or anything else of value, directly or indirectly, to any government official (including any officer or employee of a government
            or government-owned or controlled entity or of a public international organization, or any person acting in an official capacity for on behalf of any of the foregoing, or any political party or party official or candidate for political office)
            (&#8220;Government Official&#8221;) in order to influence official action, or to any person in each case, in violation of any applicable anti-corruption laws; (2) used any corporate funds for any unlawful contribution, gift, entertainment or other unlawful
            expense relating to political activity; (3) made any direct or indirect unlawful payment to any Government Official from corporate funds; (4) violated or is in violation of any provision of the Foreign Corrupt Practices Act of 1977, as amended,
            or any other applicable anti-corruption laws; or (5) made any bribe, unlawful rebate, payoff, influence payment, kickback or other unlawful payment or promise to pay;</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">12</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(xxxii)</font><font style="font-size: 10pt;"> &#160;&#160; <font style="font-family: 'Times New Roman';">The operations of the Company and its
            Subsidiaries are and have been conducted at all times in material compliance with all applicable financial recordkeeping and reporting requirements, including those of the Bank Secrecy Act, as amended by Title III of the Uniting and
            Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001 (USA PATRIOT Act), and the applicable anti-money laundering statutes of jurisdictions where the Company and its Subsidiaries conduct
            business, the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by any governmental or regulatory agency (collectively, the &#8220;Anti-Money Laundering Laws&#8221;), and no
            action, suit or proceeding by or before any court or governmental or regulatory agency, authority or body or any arbitrator involving the Company or any of its Subsidiaries with respect to the Anti-Money Laundering Laws is pending or, to the
            knowledge of the Company, threatened;</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(xxxiii)&#160; </font><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';">(1)</font>&#160;&#160;&#160;&#160;&#160;&#160; Neither the Company nor any of its Subsidiaries (collectively, the &#8220;Entity&#8221;) or any director, officer, employee thereof, or, to the Entity&#8217;s knowledge, any agent, affiliate or representative of the Entity, is an
            individual or entity (&#8220;Person&#8221;) that is, or is owned or controlled, as defined under applicable regulations, by one or more Persons that are, (a) the target of any sanctions administered or enforced by the U.S. Department of Treasury&#8217;s Office
            of Foreign Assets Control, the United Nations Security Council, the European Union, His Majesty&#8217;s Treasury or other applicable sanctions authority of a jurisdiction in which the Company conducts business (collectively, &#8220;Sanctions&#8221;), or (b)
            located, organized or resident in a country or territory that is the &#8220;target of Sanctions&#8221; (as defined in (3) below);</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-indent: 144pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(2)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Unless authorized under or not otherwise prohibited
            under the relevant Sanctions laws and regulations, the Company and its Subsidiaries will not, directly or indirectly, use the proceeds of the offering of the Shares, or lend, contribute or otherwise make available such proceeds to any
            subsidiary, joint venture partner or other Person, (a) to fund or facilitate any activities or business of or with any Person or in any country or territory that, at the time of such funding or facilitation, is the target of Sanctions; or (b)
            in any other manner that will result in a violation of Sanctions by any Person (including any Person participating in the offering pursuant to this Agreement, whether as underwriter, advisor, investor or otherwise);</font></font> </div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 144pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(3)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The Entity has not knowingly engaged
            in, is not now knowingly engaged in, and will not engage in, any dealings or transactions with any Person, or in any country or territory, that at the time of the dealing or transaction is or was the target of Sanctions unless authorized under
            or not otherwise prohibited by the relevant Sanctions laws and regulations. The &#8220;target of Sanctions&#8221; means: (i) any country or territory that is the subject of country-wide or territory-wide Sanctions, including as of the date of this
            Agreement, the so-called Donetsk People&#8217;s Republic, the so-called Luhansk People&#8217;s Republic, the non-government controlled areas of the Zaporizhzhia and Kherson Regions of Ukraine and any other &#8220;Covered Region&#8221; of Ukraine identified pursuant to
            Executive Order 14065, Crimea, Cuba, Iran, North Korea, and, prior to July 1, 2025, Syria; (ii) a Person that is on the list of Specially Designated Nationals and Blocked Persons published by the Department of Treasury&#8217;s Office of Foreign
            Assets Control or any equivalent list of sanctioned persons issued by the United Nations Security Council, the European Union, and His Majesty&#8217;s Treasury; or (iii) a person or entity that is located in or organized under the laws of a country
            or territory that is identified as the subject of country-wide or territory-wide Sanctions by the Department of Treasury&#8217;s Office of Foreign Assets Control, the United Nations Security Council, the European Union, and His Majesty&#8217;s Treasury;</font></font></div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';"><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">13</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 108pt;">
        <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(xxxiv)</font><font style="font-size: 10pt;">&#160; <font style="font-family: 'Times New Roman';">There is and has been no failure on
              the part of the Entity or any of the Entity&#8217;s directors or officers, in their capacities as such, to comply with any provision of the Sarbanes-Oxley Act of 2002, as amended, and the rules and regulations promulgated in connection therewith,
              including Section 402 related to loans and Sections 302 and 906 related to certifications;</font></font></div>
      </div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"> <br>
        </font></div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(xxxv)</font><font style="font-size: 10pt;">&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">(1) The Company and each of its
            Subsidiaries have complied, and are presently in compliance, with their privacy and security policies and with all privacy- and data security-related contractual obligations, laws and regulations regarding their collection, use, transfer,
            storage, protection, disposal or disclosure of personally identifiable information or any other information collected from or provided by third parties; (2) the Company and its Subsidiaries have taken commercially reasonable steps to protect
            the information technology and computer systems, networks, hardware, software, data and databases within the control of the Company or its Subsidiaries (including any such data and information of its customers, employees, suppliers, vendors and
            any third party data) (collectively, &#8220;IT Systems and Data&#8221;); (3) the Company and its Subsidiaries have used reasonable efforts to establish, and have established, commercially reasonable disaster recovery measures for their business, including,
            without limitation, for the IT Systems and Data and have implemented commercially reasonable controls, policies, procedures, and technological safeguards to maintain and protect the integrity, substantially continuous operation, redundancy and
            security of its IT Systems and Data reasonably consistent with generally adopted industry standards and practices, or as required by applicable regulatory standards and has complied in all material respects, and presently is in compliance in
            all material respects, with all applicable laws or statutes and all applicable judgments, orders, rules and regulations of any governmental agency, and the Company&#8217;s and its Subsidiaries&#8217; internal policies and contractual obligations relating
            to the privacy and security of IT Systems and Data and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation or modification; and (4) to the Company&#8217;s knowledge, there has been no security breach, attack,
            unauthorized access or disclosure, or other compromise of any such IT Systems and Data, except in the case of (1) through (4), as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect;</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(xxxvi)</font><font style="font-size: 10pt;">&#160;&#160; <font style="font-family: 'Times New Roman';">There are no persons with registration
            rights or other similar rights to have securities registered pursuant to the Registration Statement or otherwise registered by the Company under the Securities Act, except for such rights that have been effectively waived;</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(xxxvii)</font><font style="font-size: 10pt;"> <font style="font-family: 'Times New Roman';">The Company is not and, after giving
            effect to the offering and sale of the Shares as contemplated herein and the application of the net proceeds therefrom as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, will not be an &#8220;investment
            company,&#8221; as such term is defined in the Investment Company Act of 1940, as amended (the &#8220;Investment Company Act&#8221;);</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">14</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(xxxviii)</font><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman';"> The Company has not distributed and,
            prior to the later to occur of the Closing Date (as defined in Section 4 hereof) and completion of distribution of the Shares, will not distribute any offering materials in connection with the offering and sale of the Shares, other than the
            Preliminary Prospectus, the Prospectus and, subject to compliance with Section 6 hereof, any Issuer Free Writing Prospectus; and the Company has not taken and will not take, directly or indirectly, any action designed to cause or result in, or
            which constitutes or might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale of the Shares.&#160; The Company (a) has not alone engaged in any
            Testing-the-Waters Communication other than Testing-the-Waters Communications with the consent of the Representatives (x) with entities that are qualified institutional buyers (&#8220;QIBs&#8221;) within the meaning of Rule 144A under the Securities Act or
            institutions that are accredited investors within the meaning of Rule 501(a)(1), (a)(2), (a)(3), (a)(7) or (a)(8) under the Securities Act (&#8220;IAIs&#8221;) and otherwise in compliance with the requirements of Rule 163B of the Securities Act or (y) with
            entities that the Company reasonably believed to be QIBs or IAIs and otherwise in compliance with the requirements of Rule 163B under the Securities Act and (b) has not authorized anyone other than the Representatives to engage in
            Testing-the-Waters Communications.&#160; The Company reconfirms that the Representatives have been authorized to act on its behalf in undertaking Testing-the-Waters Communications.&#160; The Company has not distributed any Written Testing-the-Waters
            Communications other than those listed on Schedule II hereto.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(xxxix)</font><font style="font-size: 10pt;">&#160;&#160; <font style="font-family: 'Times New Roman';">The statistical and market and
            industry-related data included in the Registration Statement, the Pricing Disclosure Package and the Prospectus are based on or derived from sources which the Company reasonably believes to be reliable and accurate or represent the Company&#8217;s
            good faith estimates that are made on the basis of data derived from such sources, and the Company has obtained the written consent to the use of such data from sources to the extent required;</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(xl)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Any certificate signed by any officer
            of the Company delivered to the Underwriters or to counsel for the Underwriters shall be deemed a representation and warranty by the Company to the Underwriters as to the matters covered thereby; and</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(xli)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; &#160; <font style="font-family: 'Times New Roman';">Each financial or operational
            projection or other &#8220;forward-looking statement&#8221; (as defined by Section 27A of the Securities Act or Section 21E of the Exchange Act) contained in the Registration Statement, the Pricing Disclosure Package and the Prospectus (i) was so included
            by the Company in good faith and with reasonable basis after due consideration by the Company of the underlying assumptions, estimates and other applicable facts and circumstances and (ii) is accompanied by meaningful cautionary statements
            identifying those factors that could cause actual results to differ materially from those in such forward&#8209;looking statement.&#160; No such statement was made with the knowledge of an executive officer or director of the Company that it was false or
            misleading.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">15</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; <font style="font-family: 'Times New Roman';">Subject to the terms and conditions
            herein set forth, (a) the Company agrees to sell to each of the Underwriters, and each of the Underwriters agrees, severally and not jointly, to purchase from the Company, at a purchase price per share of $43.65 (the &#8220;Purchase Price&#8221;), the
            number of Firm Shares (to be adjusted by you so as to eliminate fractional shares) determined by multiplying the aggregate number of Firm Shares to be sold by the Company hereunder by a fraction, the numerator of which is the aggregate number
            of Firm Shares to be purchased by such Underwriter as set forth opposite the name of such Underwriter in Schedule I hereto and the denominator of which is the aggregate number of Firm Shares to be purchased by all of the Underwriters from the
            Company hereunder; and (b) in the event and to the extent that the Underwriters shall exercise the election to purchase Option Shares as provided below, the Company agrees to sell to each of the Underwriters, and each of the Underwriters
            agrees, severally and not jointly, to purchase from the Company, at the Purchase Price, the number of Option Shares (to be adjusted by you so as to eliminate fractional shares) determined by multiplying the number of Option Shares as to which
            such election shall have been exercised by the fraction set forth in clause (a) above.</font></font></div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 72pt;">The Company hereby grants to the Underwriters the right to purchase at their election up to 1,666,666 Option Shares, at the Purchase Price, for the
        sole purpose of covering over-allotments in connection with the sale of the Firm Shares.&#160; The Underwriters may exercise their option to acquire Option Shares in whole or in part from time to time only by written notice from the Representatives to
        the Company, given within a period of 30 calendar days after the date of this Agreement and setting forth the aggregate number of Option Shares to be purchased and the date on which such Option Shares are to be delivered, as determined by the
        Representatives but in no event earlier than the Closing Date or, unless the Representatives and the Company otherwise agree in writing, earlier than one business day or later than ten business days after the date of such notice.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">3.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman';">It is understood that the several
            Underwriters propose to offer the Firm Shares for sale to the public upon the terms and conditions set forth in the Prospectus.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">4.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The Company will deliver the Firm
            Shares to the Representatives through the facilities of the Depository Trust Company (&#8220;DTC&#8221;) for the accounts of the Underwriters, against payment of the purchase price therefor in Federal (same day) funds by wire transfer drawn to the order of
            the Company, at 10:00 A.M., New York time, on May 21, 2026, or at such other time not later than seven full business days thereafter as Stifel, Nicolaus &amp; Company, Incorporated (&#8220;Stifel&#8221;) and the Company determine, such time being herein
            referred to as the &#8220;Closing Date.&#8221;&#160; For purposes of Rule 15c6-1 under the Exchange Act, the Closing Date (if later than the otherwise applicable settlement date) shall be the settlement date for payment of funds and delivery of securities for
            all the Firm Shares.&#160; The certificates, if any, for the Firm Shares so to be delivered will be in definitive form, in such denominations and registered in such names as the Representatives request and will be made available for checking and
            packaging at the office of Computershare Trust Company, N.A. at least 24 hours prior to the Closing Date.</font></font></div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;"> Each time for the delivery of and payment for the Option Shares, being herein referred to as an &#8220;Option Closing Date,&#8221; which may be the Closing
        Date, shall be determined by the Representatives as provided above.&#160; The Company will deliver the Option Shares being purchased on each Option Closing Date to the Representatives through the facilities of DTC for the accounts of the Underwriters,
        against payment of the purchase price therefor in Federal (same day) funds by wire transfer drawn to the order of the Company at 10:00 A.M., New York time on the applicable Option Closing Date.&#160; The certificates, if any, for the Option Shares so to
        be delivered will be in definitive form, in such denominations and registered in such names as the Representatives request and will be made available for checking and packaging at the office of Computershare Trust Company, N.A. at least 24 hours
        prior to such Option Closing Date.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">16</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">5.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman';">The Company covenants and agrees
            with each of the Underwriters as follows:</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The Company, subject to Section 5(b),
            will comply with the requirements of Rule 430B under the Securities Act, and will notify the Representatives promptly, and confirm the notice in writing (which may occur by email), (i) when any post-effective amendment to the Registration
            Statement shall become effective, or any supplement to the Prospectus or any amended prospectus shall have been filed, to furnish the Representatives with copies thereof, and to file promptly all material required to be filed by the Company
            with the Commission pursuant to Rule 433(d) under the Securities Act, (ii) of the receipt of any comments from the Commission, (iii) of any request by the Commission for any amendment to the Registration Statement or any amendment or supplement
            to the Prospectus or for additional information, and (iv) of the issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement or of any order preventing or suspending the use of the Preliminary
            Prospectus, or of the suspension of the qualification of the Shares for offering or sale in any jurisdiction, or of the initiation or threatening of any proceedings for any of such purposes, at any time prior to the later of (A) completion of
            the distribution of the Shares within the meaning of the Securities Act and (B) completion of the 60-day restricted period referred to in Section 5(j) hereof.&#160; The Company will promptly effect the filings necessary pursuant to Rule 424(b) under
            the Securities Act and will take such steps as it deems necessary to ascertain promptly whether the form of prospectus transmitted for filing under Rule 424(b) was received for filing by the Commission and, in the event that it was not, it will
            promptly file such prospectus.&#160; The Company will make every reasonable effort to prevent the issuance of any stop order described in this section and, if any such stop order is issued, to obtain the lifting thereof at the earliest possible
            moment.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman';">Until the later of (A) completion of
            the distribution of the Shares within the meaning of the Securities Act and (B) completion of the 60-day restricted period referred to in Section 5(j) hereof, the Company will give the Representatives notice of its intention to file or prepare
            any amendment to the Registration Statement (including any filing under Rule 462(b) under the Securities Act), or any amendment, supplement or revision to the Prospectus, or any Issuer Free Writing Prospectus, will furnish the Representatives
            with copies of any such documents a reasonable amount of time prior to such proposed filing or use, as the case may be, and will not file or use any such document to which the Representatives or counsel for the Underwriters shall reasonably
            object.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The Company will use its commercially
            reasonable efforts to qualify the Shares for offering and sale under the securities laws of such jurisdictions as you may reasonably request and to comply with such laws so as to permit the continuance of sales and dealings therein in such
            jurisdictions for as long as may be necessary to complete the distribution of the Shares, provided that nothing in this Section 5(c) shall require the Company to qualify as a foreign corporation in any jurisdiction in which it is not already so
            qualified, or to file a general consent to service of process in any jurisdiction or subject itself to taxation in any jurisdiction in which it was not otherwise subject to taxation.</font></font></div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman';"> <br>
          </font></font></div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">17</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">If requested by the Representatives,
            the Company will deliver to the Representatives, without charge, three signed copies of the Registration Statement as originally filed, the Pricing Disclosure Package, the Prospectus, and of each amendment to each (including exhibits filed
            therewith or incorporated by reference therein) and signed copies of all consents and certificates of experts, and will also, upon your request, deliver to the Representatives, without charge, a conformed copy of the Registration Statement as
            originally filed and of each amendment thereto (without exhibits) for each of the Underwriters.&#160; The copies of the Registration Statement and each amendment thereto furnished to the Underwriters will be identical to the electronically
            transmitted copies thereof filed with the Commission pursuant to EDGAR, except to the extent permitted by Regulation S-T.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The Company has delivered to each
            Underwriter, without charge, as many written and electronic copies of the Preliminary Prospectus as such Underwriter reasonably requested, and the Company hereby consents to the use of such copies for purposes permitted by the Securities Act.&#160;
            The Company will furnish to each Underwriter, without charge, prior to 5:00 P.M. (New York time) on the business day next succeeding the date of this Agreement (or such later time as may be agreed to by the Company and the Representatives) and
            from time to time thereafter during the period when the Prospectus is required to be delivered in connection with sales of the Shares under the Securities Act or the Exchange Act or in lieu thereof, the notice referred to in Rule 173(a) under
            the Securities Act, such number of written and electronic copies of the Prospectus (as amended or supplemented) as such Underwriter may reasonably request.&#160; The Prospectus and any amendments or supplements thereto furnished to the Underwriters
            will be identical to the electronically transmitted copies thereof filed with the Commission pursuant to EDGAR, except to the extent permitted by Regulation S-T.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(f)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">The Company will comply with the Securities Act, the Rules and Regulations and the Exchange Act so as to permit the completion of the distribution of the Shares as contemplated in this Agreement and in the
              Prospectus. If at any time when, in the opinion of counsel for the Underwriters, a prospectus is required to be delivered in connection with sales of the Shares under the Securities Act or the Exchange Act (or in lieu thereof, the notice
              referred to in Rule 173(a) under the Securities Act), any event shall occur or condition shall exist as a result of which it is necessary, in the opinion of counsel for the Underwriters or for the Company, to amend the Registration Statement
              or amend or supplement the Prospectus or to file under the Exchange Act any document which would be deemed to be incorporated by reference in the Prospectus in order that the Prospectus will not include any untrue statements of a material
              fact or omit to state a material fact necessary in order to make the statements therein not misleading in the light of the circumstances existing at the time it (or in lieu thereof, the notice referred to in Rule 173(a) under the Securities
              Act) is delivered to a purchaser, or if it shall be necessary, in the opinion of either such counsel, at any such time to amend the Registration Statement or amend or supplement the Prospectus in order to comply with the requirements of the
              Securities Act, the Rules and Regulations or the Exchange Act, the Company will promptly prepare and file with the Commission, subject to Section 5(b), such amendment or supplement as may be necessary to correct such statement or omission or
              to make the Registration Statement or the Prospectus or any document which would be deemed to be incorporated by reference in the Prospectus in order to comply with the Securities Act or the Exchange Act, and the Company will furnish to the
              Underwriters such number of written and electronic copies of such amendment or supplement as the Underwriters may reasonably request. The Company will provide the Representatives with notice of the occurrence of any event during the period
              specified above that may give rise to the need to amend or supplement the Registration Statement or the Prospectus as provided in the preceding sentence promptly after the occurrence of such event</font>.&#160; If at any time following the
            distribution of any Written Testing-the-Waters Communication there occurred or occurs an event or development as a result of which such Written Testing-the-Waters Communication included or would include an untrue statement of a material fact or
            omitted or would omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances existing at that subsequent time, not misleading, the Company will promptly notify the Representatives and will
            promptly amend or supplement, at its own expense, such Written Testing-the-Waters Communication to eliminate or correct such untrue statement or omission.</font></font></div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">18</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(g)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman';">The Company will make generally
            available (within the meaning of Section 11(a) of the Securities Act) to its security holders and to the Representatives as soon as practicable (which may be satisfied by filing with EDGAR), but not later than 45 days after the end of its
            fiscal quarter in which the first anniversary date of the effective date of the Registration Statement occurs, an earnings statement of the Company (which need not be audited) (in form complying with the provisions of Rule 158 under the
            Securities Act) covering a period of at least twelve consecutive months beginning after the effective date of the Registration Statement.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(h)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman';">The Company will use the net proceeds
            received by it from the sale of the Shares in the manner specified in the Pricing Disclosure Package and the Prospectus under the heading &#8220;Use of Proceeds.&#8221;</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">The Company will use its best efforts
            to list, subject to notice of issuance, the Shares on the Nasdaq Global Select Market.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(j)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">During a period of 60 days from the
            date of the Prospectus, the Company will not, without the prior written consent of Stifel, (i) offer, pledge, sell, issue, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option,
            right or warrant to purchase, lend or otherwise transfer or dispose of, directly or indirectly, any Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock, (ii) enter into any swap or other agreement
            that transfers, in whole or in part, any of the economic consequences of ownership of Common Stock, whether any such transaction described in clause (i) or (ii) above is to be settled by delivery of Common Stock or such other securities, in
            cash or otherwise, or (iii) file any registration statement with the Commission relating to the offering of any shares of Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock, other than (1) the Shares
            to be sold hereunder, (2) pursuant to equity incentive or employee stock purchase plans existing on, or upon the exercise, net exercise, net settlement, conversion or exchange of exercisable, convertible or exchangeable securities outstanding
            as of the date of this Agreement and in each case, described in the Pricing Disclosure Package and the Prospectus, (3) the issuance by the Company of Common Stock or securities convertible into, exchangeable for or that represent the right to
            receive Common Stock in connection with (i) the acquisition by the Company or any of its subsidiaries of the securities, business, technology, property or other assets of another person or entity or pursuant to an employee benefit plan assumed
            by the Company in connection with such acquisition or (ii) the Company&#8217;s joint ventures, equipment leasing arrangements, debt financings and other strategic transactions, or (4) the filing of, or amendment to, any registration statement on Form
            S-8 relating to securities granted or to be granted pursuant to the Company&#8217;s equity incentive plans that are described in the Pricing Disclosure Package and the Prospectus or any assumed employee benefit plan contemplated by clause (3);
            provided that the aggregate number of shares of Common Stock that the Company may sell or issue or agree to sell or issue pursuant to clause (3) shall not exceed 10% of the total number of shares of Common Stock outstanding immediately
            following the completion of the transactions contemplated by this Agreement; and provided, further, that in the case of clause (3), each recipient of such securities shall execute and deliver to the Representatives, on or prior to the issuance
            of such securities, a lock-up agreement substantially to the effect set forth in Exhibit A hereto.</font></font></div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman';"> <br>
          </font></font></div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">19</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(k)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-family: 'Times New Roman';">The Company, during the period when
            the Prospectus is required to be delivered in connection with sales of the Shares under the Securities Act or the Exchange Act (or in lieu thereof, the notice referred to in Rule 173(a) under the Securities Act), will file all documents
            required to be filed with the Commission pursuant to the Exchange Act within the time periods required by the Exchange Act and the rules and regulations of the Commission thereunder.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(l)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">The Company will file with the
            Commission such information on Form 10-Q or Form 10-K as may be required pursuant to Rule 463 under the Securities Act.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(m)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">During a period of three years from
            the effective date of the Registration Statement, so long as the Company is subject to the reporting requirements of either Section 13 or 15(d) of the Exchange Act, the Company will furnish to you copies of all reports or other communications
            (financial or other) furnished to stockholders generally, and deliver to you as soon as they are available, copies of any reports and financial statements furnished to or filed with the Commission or any national securities exchange on which
            any class of securities of the Company is listed; provided, however, that the Company shall not be required to provide documents (i) that are available through EDGAR or (ii) the provision of which would require public disclosure by the Company
            under Regulation FD.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(n)</font><font style="font-size: 10pt;">&#160;&#160;&#160; &#160; &#160;&#160; <font style="font-family: 'Times New Roman';">If so requested by the
            Representatives, the Company shall cause to be prepared and delivered, at its expense, within one business day from the effective date of this Agreement (or such later time as may be agreed to by the Company and the Representatives), to the
            Representatives an &#8220;electronic Prospectus&#8221; to be used by the Underwriters in connection with the offering and sale of the Shares. As used herein, the term &#8220;electronic Prospectus&#8221; means a form of the most recent Preliminary Prospectus, any
            Issuer Free Writing Prospectus or the Prospectus, and any amendment or supplement thereto, that meets each of the following conditions: (i) it shall be encoded in an electronic format, satisfactory to the Representatives, that may be
            transmitted electronically by the Representatives and the other Underwriters to offerees and purchasers of the Shares, (ii) it shall disclose the same information as such paper Preliminary Prospectus, Issuer Free Writing Prospectus or the
            Prospectus, as the case may be, and (iii) it shall be in or convertible into a paper format or an electronic format, satisfactory to the Representatives, that will allow investors to store and have continuously ready access to such Preliminary
            Prospectus, Issuer Free Writing Prospectus or the Prospectus at any future time, without charge to investors (other than any fee charged for subscription to the Internet generally).&#160; The Company hereby confirms that, if so requested by the
            Representatives, it has included or will include in the Prospectus filed with the Commission an undertaking that, upon receipt of a request by an investor or his or her representative, the Company shall transmit or cause to be transmitted
            promptly, without charge, a paper copy of such paper Preliminary Prospectus, Issuer Free Writing Prospectus or the Prospectus to such investor or representative.</font></font></div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman';"> <br>
          </font></font></div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">20</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(o)</font><font style="font-size: 10pt;">&#160;&#160; &#160; &#160;&#160; <font style="font-family: 'Times New Roman';">The Company agrees to pay the required
            Commission filing fees relating to the Shares within the time required by Rule 456(b)(1) under the Securities Act or any similar rule without regard to the proviso therein and otherwise in accordance with Rules 456(b) and 457(r) under the
            Securities Act.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">6.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Company represents and agrees that, without the prior consent of the Representatives, it has not made and will not make any offer relating to the Shares that would constitute a &#8220;free writing prospectus&#8221; as
            defined in Rule 405 under the Securities Act; each Underwriter represents and agrees that, without the prior consent of the Company and the Representatives, it has not made and will not make any offer relating to the Shares that would
            constitute a free writing prospectus; any such free writing prospectus the use of which has been consented to by the Company and the Representatives is listed on Schedule II hereto;</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The Company has complied and will
            comply with the requirements of Rule 433 under the Securities Act applicable to any Issuer Free Writing Prospectus, including timely filing with the Commission or retention where required and legending; the Company represents that it has
            satisfied and agrees that it will satisfy the conditions under Rule 433 under the Securities Act to avoid a requirement to file with the Commission any electronic road show;</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-family: 'Times New Roman';">The Company agrees that if at any time
            following issuance of an Issuer Free Writing Prospectus any event occurred or occurs as a result of which such Issuer Free Writing Prospectus would conflict with the information in the Registration Statement, the Pricing Disclosure Package or
            the Prospectus, or when taken together with the information in the Pricing Disclosure Package and other Issuer Free Writing Prospectuses, would include an untrue statement of a material fact or omit to state any material fact necessary in order
            to make the statements therein, in light of the circumstances then prevailing, not misleading, the Company will give prompt notice thereof to the Representatives and, if requested by the Representatives, will prepare and furnish without charge
            to each Underwriter an Issuer Free Writing Prospectus or other document which will correct such conflict, statement or omission; provided, however, that this covenant shall not apply to any statements or omissions in an Issuer Free Writing
            Prospectus made in reliance upon and in strict conformity with information furnished in writing to the Company by an Underwriter through the Representatives in their capacities as such expressly for use therein.</font></font></div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">21</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">7.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman';">The Company covenants and agrees with
            the several Underwriters that, whether or not the transactions contemplated by this Agreement are consummated, the Company will pay or cause to be paid all expenses incident to the performance of its obligations under this Agreement, including
            the following: (i) the fees, disbursements and expenses of the Company&#8217;s counsel, accountants and other advisors; (ii) filing fees and all other expenses in connection with the preparation, printing and filing of the Registration Statement, the
            Preliminary Prospectus, any Issuer Free Writing Prospectus and the Prospectus and amendments and supplements thereto and the mailing and delivering of copies thereof to the Underwriters and dealers; (iii) the cost of printing or producing this
            Agreement, closing documents (including any compilations thereof) and such other documents as may be required in connection with the offering, purchase, sale and delivery of the Shares; (iv) all filing fees in connection with the qualification
            of the Shares for offering and sale under state securities laws as provided in Section 5(c); (v) all fees and expenses in connection with listing the Shares on the Nasdaq Global Select Market; (vi) the filing fees incident to, and the
            reasonable and documented fees and disbursements of counsel for the Underwriters in connection with, securing any required review by FINRA of the terms of the sale of the Shares (not to exceed $25,000 in the aggregate); (vii) all fees and
            expenses in connection with the preparation, issuance and delivery of the certificates representing the Shares to the Underwriters, if any, including any stock or other transfer taxes and any stamp or other duties payable upon the sale,
            issuance or delivery of the Shares to the Underwriters; (viii) the cost and charges of any transfer agent or registrar; (ix) the transportation (other than 50% of the cost of any chartered aircraft if necessary for transportation to investor
            meetings as part of the road show and approved by the Company, to be paid by the Underwriters) and other expenses incurred by the Company in connection with presentations to prospective purchasers of Shares (not including the Underwriters and
            their representatives), including any costs and expenses relating to the preparation of any investor presentations or road show presentations (including electronic road shows and any road show slides, graphics or videos); and (x) all other
            costs and expenses incident to the performance of the Company&#8217;s obligations hereunder which are not otherwise specifically provided for in this Section. It is understood that, subject to this Section 7 and Section 12, the Underwriters will pay
            all of their costs and expenses associated with the transactions contemplated hereunder, including, but not limited to, all fees and disbursements of their counsel, stock transfer taxes on resale of any of the Shares by them, any advertising
            expenses connected with any offers they may make, 50% of the cost of any chartered aircraft if necessary for transportation to investor meetings as part of the road show and approved by the Company, and the costs of meals for investor meetings
            on the road show.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">8.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman';">The several obligations of the
            Underwriters hereunder to purchase the Shares on the Closing Date or each Option Closing Date, as the case may be, are subject to the performance by the Company of its obligations hereunder and to the following additional conditions:</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160; &#160;&#160; &#160; <font style="font-family: 'Times New Roman';">The Prospectus shall have been filed
            with the Commission pursuant to Rule 424(b) under the Securities Act within the applicable time period prescribed for such filing by the Rules and Regulations and in accordance with Section 5(a); all material required to be filed by the Company
            pursuant to Rule 433(d) under the Securities Act shall have been filed with the Commission within the applicable time period prescribed for such filing by Rule 433 under the Securities Act; if the Company has elected to rely upon Rule 462(b)
            under the Securities Act, the Rule 462(b) Registration Statement shall have become effective by 10:00 P.M., Washington, D.C. time, on the date of this Agreement; no stop order suspending the effectiveness of the Registration Statement or any
            part thereof or any amendment thereto shall have been issued and no proceeding for that purpose shall have been initiated or threatened by the Commission or any state securities commission; no stop order suspending or preventing the use of the
            Pricing Disclosure Package or the Prospectus or any part thereof or any Issuer Free Writing Prospectus shall have been issued and no proceeding for that purpose shall have been initiated or threatened by the Commission; and all requests for
            additional information on the part of the Commission shall have been complied with to your reasonable satisfaction.</font></font></div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman';"> <br>
          </font></font></div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">22</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The representations and warranties of
            the Company contained herein are true and correct on and as of the Closing Date or the Option Closing Date, as the case may be, as if made on and as of the Closing Date or the Option Closing Date, as the case may be, and the Company shall have
            complied with all agreements and all conditions on its part to be performed or satisfied hereunder at or prior to the Closing Date or the Option Closing Date, as the case may be.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Subsequent to the execution and
            delivery of this Agreement and prior to the Closing Date or the Option Closing Date, as the case may be, there shall not have occurred any downgrading, nor shall any notice have been given of (i) any downgrading, (ii) any intended or potential
            downgrading or (iii) any review or possible change that does not indicate an improvement, in the rating accorded any securities of or guaranteed by the Company or any Subsidiary by any &#8220;nationally recognized statistical rating organization,&#8221; as
            such term is defined for purposes of Rule 436(g)(2) under the Securities Act.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">(i) The Company and its Subsidiaries,
            taken as a whole, shall not have sustained since the date of the latest audited financial statements included or incorporated by reference in the Pricing Disclosure Package and the Prospectus any material loss or interference with its business
            from fire, explosion, flood or other calamity, whether or not covered by insurance, or from any labor dispute or court or governmental action, order or decree, otherwise than as set forth or contemplated in the Pricing Disclosure Package, and
            (ii) since the respective dates as of which information is given in the Registration Statement, the Pricing Disclosure Package and the Prospectus, (1) there shall not have been any change in the capital stock (other than as a result of (i) the
            grant, vesting or exercise of stock options or other equity incentives pursuant to the Company&#8217;s equity incentive plans, or (ii) the repurchase of shares of capital stock pursuant to agreements providing for an option to repurchase or a right
            of first refusal on behalf of the Company, in each case as such (A) equity incentive plans, (B) outstanding equity incentives and (C) agreements are described in the Pricing Disclosure Package and the Prospectus) or changes in long-term debt of
            the Company or any Subsidiary (other than borrowings under the Company&#8217;s credit facilities described in the Pricing Disclosure Package and the Prospectus) or (2) there shall not have been any material adverse change, or any development that
            would reasonably be expected to result in a prospective material adverse change, in or affecting the general affairs, business, prospects, management, financial position, stockholders&#8217; equity or results of operations of the Company and the
            Subsidiaries, considered as one enterprise, other than as set forth or contemplated in the Pricing Disclosure Package and the Prospectus, the effect of which, in any such case described in clause (i) or (ii), is in the judgment of the
            Representatives so material and adverse as to make it impracticable or inadvisable to proceed with the public offering or the delivery of the Shares being delivered at such Closing Date or Option Closing Date, as the case may be, on the terms
            and in the manner contemplated in the Pricing Disclosure Package and the Prospectus.</font></font></div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman';"> <br>
          </font></font></div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">23</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160; &#160; &#160;&#160; <font style="font-family: 'Times New Roman';">The Representatives shall have
            received on and as of the Closing Date or the Option Closing Date, as the case may be, a certificate of two executive officers of the Company, at least one of whom has specific knowledge about the Company&#8217;s financial matters, satisfactory to
            the Representatives, to the effect (1) set forth in Sections 8(b) (with respect to the respective representations, warranties, agreements and conditions of the Company) and 8(c), (2) that none of the situations set forth in clause (i) or (ii)
            of Section 8(d) shall have occurred and (3) that no stop order suspending the effectiveness of the Registration Statement has been issued and to the knowledge of the Company, no proceedings for that purpose have been instituted or are pending
            or contemplated by the Commission;</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(f)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">On the Closing Date or Option Closing
            Date, as the case may be, Gibson, Dunn &amp; Crutcher LLP, counsel for the Company, shall have furnished to the Representatives their favorable written letters, dated the Closing Date or the Option Closing Date, as the case may be, in form and
            substance satisfactory to counsel for the Underwriters.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(g)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">On the date of this Agreement,
            PricewaterhouseCoopers LLP shall have furnished to the Representatives a letter, dated the date of delivery thereof, in form and substance satisfactory to the Representatives, containing statements and information of the type customarily
            included in accountants&#8217; &#8220;comfort letters&#8221; to underwriters with respect to the financial statements and certain financial information contained in the Registration Statement, the Pricing Disclosure Package and the Prospectus.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(h)</font><font style="font-size: 10pt;">&#160;&#160;&#160; &#160; &#160;&#160; <font style="font-family: 'Times New Roman';">On the Closing Date or Option Closing
            Date, as the case may be, the Representatives shall have received from PricewaterhouseCoopers LLP a letter, dated the Closing Date or such Option Closing Date, as the case may be, to the effect that they reaffirm the statements made in the
            letter or letters furnished pursuant to Section 8(g), except that the specified date referred to shall be a date not more than three business days prior to the Closing Date or such Option Closing Date, as the case may be.</font></font></div>
      <div style="font-size: 10pt;">&#160;<br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman';">On the Closing Date or Option
            Closing Date, as the case may be, Paul Hastings LLP, counsel for the Underwriters, shall have furnished to the Representatives their favorable opinion dated the Closing Date or the Option Closing Date, as the case may be, with respect to such
            matters as the Representatives may reasonably request, and such counsel shall have received such papers and information as they may reasonably request to enable them to pass upon such matters.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(j)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman';">On the Closing Date or Option Closing
            Date, as the case may be, Harrity &amp; Harrity, LLP and Mannava &amp; Kang, P.C., intellectual property counsel for the Company, each shall have furnished to the Representatives their respective favorable written opinion with respect to
            intellectual property matters, dated the Closing Date or the Option Closing Date, as the case may be, in form and substance satisfactory to counsel for the Underwriters.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(k)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman';">On the Closing Date or Option Closing
            Date, as the case may be, the Representatives shall have received a certificate of the Chief Financial Officer of the Company, satisfactory to the Representatives, certifying such matters as the Representatives may reasonably request.</font></font></div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman';"> <br>
          </font></font></div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">24</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(l)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; &#160; &#160;&#160; <font style="font-family: 'Times New Roman';">The Shares to be delivered on the
            Closing Date or Option Closing Date, as the case may be, shall have been approved for listing on the Nasdaq Global Select Market, subject to official notice of issuance.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(m)</font><font style="font-size: 10pt;">&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman';">FINRA shall not have raised any
            objection with respect to the fairness and reasonableness of the underwriting terms and conditions.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(n)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The Representatives shall have received
            &#8220;lock-up&#8221; agreements, each substantially in the form of Exhibit A hereto, from each of the executive officers and directors of the Company and such agreements shall be in full force and effect on the Closing Date or Option Closing Date, as the
            case may be.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(o)</font><font style="font-size: 10pt;">&#160;&#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman';">On or prior to the Closing Date or
            Option Closing Date, as the case may be, the Company shall have furnished to the Representatives such further information, certificates and documents as the Representatives shall reasonably request.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">(p)&#160;&#160;&#160;&#160;&#160;&#160;&#160; On or after the Applicable Time there shall not have occurred any of the following: (i) a suspension or material limitation in trading in
        securities generally on the Nasdaq Global Select Market; (ii) a suspension or material limitation in trading in the Company&#8217;s securities on the Nasdaq Global Select Market; (iii) a general moratorium on commercial banking activities declared by
        either Federal or New York State authorities or a material disruption in commercial banking or securities settlement or clearance services in the United States; (iv) the outbreak or escalation of hostilities involving the United States or the
        declaration by the United States of a national emergency or war or (v) the occurrence of any other calamity or crisis or any change in financial, political or economic conditions in the United States or elsewhere, if the effect of any such event
        specified in clauses (iv) or (v) in the judgment of the Representatives makes it impracticable or inadvisable to proceed with the public offering or the delivery of the Shares being delivered at such Closing Date or Option Closing Date, as the case
        may be, on the terms and in the manner contemplated in the Prospectus;</div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 72pt;">If any condition specified in this Section 8 shall not have been fulfilled when and as required to be fulfilled, this Agreement may be terminated,
        subject to the provisions of Section 12, by the Representatives by notice to the Company at any time at or prior to the Closing Date or Option Closing Date, as the case may be, and such termination shall be without liability of any party to any
        other party, except as provided in Section 12.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">25</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">9.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160; &#160; The Company agrees to indemnify and hold harmless each Underwriter and each person, if any, who controls any Underwriter within the meaning of Section 15 of the Securities Act or Section 20(a) of the Exchange Act
            against any and all losses, liabilities, claims, damages and expenses whatsoever as incurred (including, without limitation, reasonable attorneys&#8217; fees and any and all reasonable expenses whatsoever incurred in investigating, preparing or
            defending against any litigation, commenced or threatened, or any claim whatsoever, and subject to Section 9(c) any and all amounts paid in settlement of any claim or litigation), joint or several, to which they or any of them may become
            subject under the Securities Act, the Exchange Act or otherwise, insofar as such losses, liabilities, claims, damages or expenses (or actions in respect thereof) arise out of or are based upon (i) any untrue statement or alleged untrue
            statement of a material fact contained in the Registration Statement, or any post-effective amendment thereof<a name="z_cp_text_2_1435"></a>, including any information deemed to be a part thereof pursuant to Rule 430B, <a name="z_cp_text_2_1346"></a>or any omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, or (ii) any untrue statement or alleged untrue
            statement of a material fact contained in any Preliminary Prospectus, the Pricing Disclosure Package or the Prospectus, or in any supplement thereto or amendment thereof, any Issuer Free Writing Prospectus, any Written Testing-the-Waters
            Communication, or any &#8220;issuer information&#8221; filed or required to be filed pursuant to Rule 433(d) under the Securities Act, or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated
            therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading, and will reimburse each Underwriter for any legal or other expenses reasonably incurred by such Underwriter in
            connection with investigating or defending any such action or claim as such expenses are incurred; provided, however, that the Company will not be liable in any such case to the extent that any such loss, liability, claim, damage or expense
            arises out of or is based upon any such untrue statement or alleged untrue statement or omission or alleged omission made in the Registration Statement, or any post-effective amendment thereof, including any information deemed to be a part
            thereof pursuant to Rule 430B, any Preliminary Prospectus, the Pricing Disclosure Package, or the Prospectus, or in any supplement thereto or amendment thereof, any Issuer Free Writing Prospectus, or any Written Testing-the-Waters Communication
            in reliance upon and in strict conformity with written information furnished to the Company by or on behalf of any Underwriter through the Representatives in their capacities as such expressly for use therein, it being understood and agreed
            that the only such information furnished by any Underwriter is the information described as such in Section 9(b) below.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Each Underwriter, severally and not
            jointly, agrees to indemnify and hold harmless the Company, each of the directors of the Company, each of the officers of the Company who shall have signed the Registration Statement, and each other person, if any, who controls the Company
            within the meaning of Section 15 of the Securities Act or Section 20(a) of the Exchange Act, against any and all losses, liabilities, claims, damages and expenses whatsoever as incurred (including, without limitation, reasonable attorneys&#8217; fees
            and any and all reasonable expenses whatsoever incurred in investigating, preparing or defending against any litigation, commenced or threatened, or any claim whatsoever, and, subject to Section 9(c), any and all amounts paid in settlement of
            any claim or litigation), joint or several, to which they or any of them may become subject under the Securities Act, the Exchange Act or otherwise, insofar as such losses, liabilities, claims, damages or expenses (or actions in respect
            thereof) arise out of or are based upon (i) any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement, or any post-effective amendment thereof, including any information deemed to be a part
            thereof pursuant to Rule 430B, or any omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, or (ii) any untrue statement or alleged untrue
            statement of a material fact contained in any Preliminary Prospectus, the Pricing Disclosure Package or the Prospectus, or in any supplement thereto or amendment thereof, any Issuer Free Writing Prospectus, any Written Testing-the-Waters
            Communication, or any &#8220;issuer information&#8221; filed or required to be filed pursuant to Rule 433(d) under the Securities Act, or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated
            therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading, in each case to the extent, but only to the extent, that any such loss, liability, claim, damage or expense
            arises out of or is based upon any such untrue statement or alleged untrue statement or omission or alleged omission made therein in reliance upon and in strict conformity with written information furnished to the Company by such Underwriter
            through the Representatives expressly for use therein, it being understood and agreed that the only such information furnished by or on behalf of any Underwriter consists of the following information in the Prospectus furnished on behalf of
            each Underwriter: the last paragraph at the bottom of the cover page concerning the delivery of the Shares, the concession and reallowance figures appearing in the fourth paragraph under the caption &#8220;Underwriting&#8221; and the information relating
            to stabilizing transactions, syndicate covering transactions and penalty bids contained in the eleventh, twelfth, thirteenth, fourteenth, fifteenth, sixteenth and seventeenth paragraphs under the caption &#8220;Underwriting.&#8221;<br>
            <br>
          </font></font></div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">26</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman';">Promptly after receipt by an
            indemnified party under Section 9(a) or 9(b) of notice of the commencement of any action, such indemnified party shall, if a claim in respect thereof is to be made against the indemnifying party under such Section, notify each party against
            whom indemnification is to be sought in writing of the commencement thereof (but the failure so to notify an indemnifying party shall not relieve it from any liability which it may have under this Section 9). In case any such action is brought
            against any indemnified party, and it notifies an indemnifying party of the commencement thereof, the indemnifying party will be entitled to participate therein, and jointly with any other indemnifying party similarly notified, to the extent it
            may elect by written notice delivered to the indemnified party promptly after receiving the aforesaid notice from such indemnified party, to assume the defense thereof with counsel reasonably satisfactory to such indemnified party (who shall
            not, except with the consent of the indemnified party, be counsel to the indemnifying party). Notwithstanding the foregoing, the indemnified party or parties shall have the right to employ its or their own counsel in any such case, but the fees
            and expenses of such counsel shall be at the expense of such indemnified party or parties unless (i) the employment of such counsel shall have been authorized in writing by one of the indemnifying parties in connection with the defense of such
            action, (ii) the indemnifying parties shall not have employed counsel to have charge of the defense of such action within a reasonable time after notice of commencement of the action, or (iii) such indemnified party or parties shall have
            reasonably concluded that there may be defenses available to it or them which are different from or additional to those available to one or all of the indemnifying parties (in which case the indemnifying parties shall not have the right to
            direct the defense of such action on behalf of the indemnified party or parties), in any of which events such fees and expenses shall be borne by the indemnifying parties. In no event shall the indemnifying parties be liable for fees and
            expenses of more than one counsel (in addition to any local counsel) separate from their own counsel for all indemnified parties in connection with any one action or separate but similar or related actions in the same jurisdiction arising out
            of the same general allegations or circumstances, which counsel, in the event of indemnified parties under Section 9(a), shall be selected by the Representatives. No indemnifying party shall, without the written consent of the indemnified
            party, effect the settlement or compromise of, or consent to the entry of any judgment with respect to, any pending or threatened action or claim in respect of which indemnification or contribution may be sought hereunder (whether or not the
            indemnified party is an actual or potential party to such action or claim) unless such settlement, compromise or judgment (i) includes an unconditional release of the indemnified party from all liability arising out of such action or claim and
            (ii) does not include a statement as to or an admission of fault, culpability or a failure to act, by or on behalf of any indemnified party.</font></font></div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman';"> <br>
          </font></font></div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">27</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">If the indemnification provided for
            in this Section 9 is unavailable to or insufficient to hold harmless an indemnified party under Section 9(a) or 9(b) in respect of any losses, liabilities, claims, damages or expenses (or actions in respect thereof) referred to therein, then
            each indemnifying party shall contribute to the amount paid or payable by such indemnified party as a result of such losses, liabilities, claims, damages or expenses (or actions in respect thereof) in such proportion as is appropriate to
            reflect the relative benefits received by the Company on the one hand and the Underwriters on the other from the offering of the Shares.&#160; If, however, the allocation provided by the immediately preceding sentence is not permitted by applicable
            law, then each indemnifying party shall contribute to such amount paid or payable by such indemnified party in such proportion as is appropriate to reflect not only such relative benefits but also the relative fault of the Company on the one
            hand and the Underwriters on the other in connection with the statements or omissions which resulted in such losses, liabilities, claims, damages or expenses (or actions in respect thereof), as well as any other relevant equitable
            considerations.&#160; The relative benefits received by the Company on the one hand and the Underwriters on the other from the offering of the Shares shall be deemed to be in the same proportion as the total net proceeds from the offering (before
            deducting expenses) received by the Company bear to the total underwriting discounts and commissions received by the Underwriters, in each case as set forth in the table on the cover page of the Prospectus.&#160; The relative fault shall be
            determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the Company on the one hand or the
            Underwriters on the other and the parties&#8217; relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission.</font></font></div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">The Company and the Underwriters agree that it would not be just and equitable if contributions pursuant to this Section 9(d) were determined by pro
        rata allocation (even if the Underwriters were treated as one entity for such purpose) or by any other method of allocation which does not take account of the equitable considerations referred to above in this Section 9(d).&#160; The amount paid or
        payable by an indemnified party as a result of the losses, liabilities, claims, damages or expenses (or actions in respect thereof) referred to above in this Section 9(d) shall be deemed to include any legal or other expenses reasonably incurred by
        such indemnified party in connection with investigating or defending any such action or claim.&#160; Notwithstanding the provisions of this Section 9(d), no Underwriter shall be required to contribute any amount in excess of the amount by which the
        total price at which the Shares underwritten by it and distributed to the public exceeds the amount of any damages which such Underwriter has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged
        omission.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from
        any person who was not guilty of such fraudulent misrepresentation.&#160; The Underwriters&#8217; obligations in this Section 9(d) to contribute are several in proportion to their respective underwriting obligations and not joint.</div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">28</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The obligations of the parties to
            this Agreement contained in this Section 9 are not exclusive and shall not limit any rights or remedies which may otherwise be available to any indemnified party at law or in equity.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">10.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">If any Underwriter or Underwriters
            default in its or their obligations to purchase Shares hereunder on the Closing Date or any Option Closing Date and the aggregate number of Shares that such defaulting Underwriter or Underwriters agreed but failed to purchase does not exceed
            10% of the total number of Shares that the Underwriters are obligated to purchase on such Closing Date or Option Closing Date, as the case may be, the Representatives may make arrangements satisfactory to the Company for the purchase of such
            Shares by other persons, including any of the Underwriters, but if no such arrangements are made by such Closing Date or Option Closing Date, as the case may be, the non-defaulting Underwriters shall be obligated severally, in proportion to
            their respective commitments hereunder, to purchase the Shares that such defaulting Underwriters agreed but failed to purchase on such Closing Date or Option Closing Date, as the case may be.&#160; If any Underwriter or Underwriters so default and
            the aggregate number of Shares with respect to which such default or defaults occur exceeds 10% of the total number of Shares that the Underwriters are obligated to purchase on such Closing Date or Option Closing Date, as the case may be, and
            arrangements satisfactory to the Representatives and the Company for the purchase of such Shares by other persons are not made within 36 hours after such default, this Agreement will terminate, subject to the provisions of Section 12, without
            liability on the part of any non-defaulting Underwriter or the Company, except as provided in Section 12.&#160; Nothing herein will relieve a defaulting Underwriter from liability for its default.</font></font></div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;"> In the event of any such default which does not result in a termination of this Agreement, either the Representatives or the Company shall have the
        right to postpone the Closing Date or the relevant Option Closing Date, as the case may be, for a period not exceeding seven days in order to effect any required changes in the Registration Statement or Prospectus or in any other documents or
        arrangements.&#160; As used in this Agreement, the term &#8220;Underwriter&#8221; includes any person substituted for an Underwriter under this Section 10.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">11.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Notwithstanding anything herein
            contained, this Agreement (or the obligations of the several Underwriters with respect to any Option Shares which have yet to be purchased) may be terminated, subject to the provisions of Section 12, in the absolute discretion of the
            Representatives, by notice given to the Company, if after the execution and delivery of this Agreement and prior to the Closing Date or the Option Closing Date, as the case may be, (a) trading generally on the New York Stock Exchange or the
            Nasdaq Global Select Market shall have been suspended or materially limited, (b) trading of any securities of or guaranteed by the Company or any Subsidiary shall have been suspended on any exchange or in any over-the-counter market, (c) a
            general moratorium on commercial banking activities in New York shall have been declared by Federal or New York State authorities or a new restriction materially adversely affecting the distribution of the Firm Shares or the Option Shares, as
            the case may be, shall have become effective, or (d) there has occurred any material adverse change in the financial markets in the United States or the international financial markets, any outbreak of hostilities or escalation thereof or other
            calamity or crisis or any change or development involving a prospective change in national or international political, financial or economic conditions, in each case the effect of which is such as to make it, in the judgment of the
            Representatives, impracticable to market the Shares to be delivered on the Closing Date or Option Closing Date, as the case may be, or to enforce contracts for the sale of the Shares.</font></font></div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman';"> <br>
          </font></font></div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">29</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">If this Agreement is terminated pursuant to this Section 11, such termination will be without liability of any party to any other party except as
        provided in Section 12 hereof.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">12.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman';">The respective indemnities,
            agreements, representations, warranties and other statements of the Company or its officers and of the several Underwriters set forth in or made pursuant to this Agreement will remain in full force and effect, regardless of any investigation,
            or statement as to the results thereof, made by or on behalf of any Underwriter, the Company, or any of their respective representatives, officers or directors or any controlling person, and will survive delivery of and payment for the Shares.&#160;
            If this Agreement is terminated pursuant to Section 10,&#160; the Company shall not then be under any liability to any Underwriter except as provided in Sections 7 and 9 hereof; if this Agreement is terminated pursuant to Section 11, or if for any
            other reason, any of the Shares are not delivered by or on behalf of the Company as provided herein, the Company will reimburse the Underwriters severally for all out of pocket expenses, including fees and disbursements of counsel, reasonably
            incurred by the Underwriters in making preparations for the purchase, sale and delivery of the Shares not so delivered, but the Company shall then be under no further liability to any Underwriter except as provided in Sections 7 and 9 hereof.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">13.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">This Agreement shall inure to the
            benefit of and be binding upon the Company and the Underwriters, the officers and directors of the Company referred to herein, any controlling persons of the Company or Underwriters referred to herein and their respective successors and
            assigns.&#160; Nothing expressed or mentioned in this Agreement is intended or shall be construed to give any other person, firm or corporation any legal or equitable right, remedy or claim under or in respect of this Agreement or any provision
            herein contained.&#160; No purchaser of Shares from any Underwriter shall be deemed to be a successor or assign by reason merely of such purchase.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">14.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">All notices and other communications
            hereunder shall be in writing and shall be deemed to have been duly given upon receipt thereof by the recipient if mailed or transmitted by any standard form of telecommunication.&#160; Notices to the Underwriters shall be given to the
            Representatives, c/o Stifel, Nicolaus &amp; Company, Incorporated, 1201 Wills Street, Suite 600, Baltimore, Maryland 21231, Attention: Legal; Needham &amp; Company, LLC, 250 Park Avenue, 10<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> Floor, New York, NY 10177, Attention:
            Corporate Finance Department.&#160; Notices to the Company shall be given to it at Viavi Solutions Inc., 1445 South Spectrum Blvd., Suite 102, Chandler, Arizona 85286; Attention: Secretary; with a copy to (which shall not constitute notice) Gibson,
            Dunn &amp; Crutcher LLP, 310 University Avenue, Palo Alto, CA 94301; Attention: Ed Batts and Robyn Zolman.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">15.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman';">This Agreement may be signed in
            counterparts, each of which shall be an original and all of which together shall constitute one and the same instrument.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">16.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">THIS AGREEMENT SHALL BE GOVERNED BY
            AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK, WITHOUT REGARD TO SUCH STATE&#8217;S PRINCIPLES OF CONFLICTS OF LAWS.</font></font></div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman';"> <br>
          </font></font></div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">30</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">17.</font><font style="font-size: 10pt;"> &#160;&#160; &#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The parties hereby submit to the
            jurisdiction of and venue in the federal courts located in the City of New York, New York in connection with any dispute related to this Agreement, any transaction contemplated hereby, or any other matter contemplated hereby.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">18.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman';">The Company acknowledges and agrees
            that (i) the purchase and sale of the Shares pursuant to this Agreement, including the determination of the public offering price of the Shares and any related discounts and commissions, is an arm&#8217;s-length commercial transaction between the
            Company on the one hand, and the several Underwriters, on the other, (ii) in connection therewith and with the process leading to such transaction each Underwriter is acting solely as a principal and not the agent or fiduciary of the Company,
            or its respective stockholders, creditors, employees or any other party, (iii) no Underwriter has assumed an advisory or fiduciary responsibility in favor of the Company with respect to the offering contemplated hereby or the process leading
            thereto (irrespective of whether such Underwriter has advised or is currently advising the Company on other matters) or any other obligation to the Company except the obligations expressly set forth in this Agreement, and (iv) the Company has
            consulted its own legal and financial advisors to the extent it deemed appropriate.&#160; The Company agrees that it will not claim that the Underwriters, or any of them, has rendered advisory services of any nature or respect, or owes a fiduciary
            or similar duty to the Company, in connection with such transaction or the process leading thereto.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">19.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The Company acknowledges that the
            Underwriters&#8217; research analysts and research departments are required to be independent from their respective investment banking divisions and are subject to certain regulations and internal policies, and that such Underwriters&#8217; research
            analysts may hold views and make statements or investment recommendations and/or publish research reports with respect to the Company and/or the offering that differ from the views of their respective investment banking divisions.&#160; The Company
            hereby waives and releases, to the fullest extent permitted by law, any claims that the Company may have against the Underwriters with respect to any conflict of interest that may arise from the fact that the views expressed by their
            independent research analysts and research departments may be different from or inconsistent with the views or advice communicated to the Company by such Underwriters&#8217; investment banking divisions.&#160; The Company acknowledges that each of the
            Underwriters is a full service securities firm and as such from time to time, subject to applicable securities laws, may effect transaction for its own account or the account of its customers and hold long or short positions in debt or equity
            securities of the companies that may be the subject of the transactions contemplated by this Agreement.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">20.</font><font style="font-size: 10pt;">&#160;&#160;&#160; &#160;&#160; &#160; <font style="font-family: 'Times New Roman';">Notwithstanding anything herein to
            the contrary, the Company is authorized to disclose to any persons the U.S. federal and state income tax treatment and tax structure of the potential transaction and all materials of any kind (including tax opinions and other tax analyses)
            provided to the Company relating to that treatment and structure, without the Underwriters imposing any limitation of any kind.&#160; However, any information relating to the tax treatment and tax structure shall remain confidential (and the
            foregoing sentence shall not apply) to the extent necessary to enable any person to comply with securities laws.&#160; For this purpose, &#8220;tax structure&#8221; is limited to any facts that may be relevant to that treatment.</font></font></div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman';"> <br>
          </font></font></div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">31</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">21.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman';">This Agreement supersedes all prior
            agreements and understandings (whether written or oral) between the Company and the Underwriters, or any of them, with respect to the subject matter hereof.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">22.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman';">The Company and each of the
            Underwriters hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to this Agreement or the transactions contemplated hereby.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">23.</font><font style="font-size: 10pt;">&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman';">(a) In the event that any Underwriter
            that is a Covered Entity becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same
            extent as the transfer would be effective under the U.S. Special Resolution Regime if this Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of the United States.</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; (b) In the event that any Underwriter that is a Covered Entity or a BHC Act Affiliate of such Underwriter becomes subject to a
        proceeding under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S.
        Special Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 54pt;">As used in this Section 23:</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 54pt;">&#8220;BHC Act Affiliate&#8221; has the meaning assigned to the term &#8220;affiliate&#8221; in, and shall be interpreted in accordance with, 12 U.S.C. Section 1841(k).</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 54pt;">&#8220;Covered Entity&#8221; means any of the following: (i) a &#8220;covered entity&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R.
        Section 252.82(b); (ii) a &#8220;covered bank&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. Section 47.3(b); or (iii) a &#8220;covered FSI&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R Section 382.2(b).</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 54pt;">&#8220;Default Right&#8221; has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R Sections 252.81, 47.2 or 382.1, as
        applicable.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 54pt;">&#8220;U.S. Special Resolution Regime&#8221; means each of (i) the Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii) Title II of
        the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder.</div>
      <div style="text-align: justify; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">32</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div style="text-align: justify; font-size: 10pt; text-indent: 36pt;"><font style="font-family: 'Times New Roman';">If the foregoing is in accordance with your understanding of our agreement, please sign and return to the Company a counterpart
          hereof, whereupon this instrument will become a binding agreement among the Company and the Underwriters.</font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="zf6df8b59b8d94302bd1e04c8a90f5666" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;"><br>
            </td>
            <td colspan="2" rowspan="1" style="width: 3.48%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: justify; font-family: 'Times New Roman';">Very truly yours,</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;"><br>
            </td>
            <td style="width: 3.48%; vertical-align: top; font-size: 10pt;"><br>
            </td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt;"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;"><br>
            </td>
            <td style="width: 3.48%; vertical-align: top; font-size: 10pt;" rowspan="1" colspan="2">
              <div style="text-align: justify; font-family: 'Times New Roman';">VIAVI SOLUTIONS INC.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
            <td style="width: 3.48%; vertical-align: top; font-size: 10pt;" rowspan="1"><br>
            </td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt;" rowspan="1"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;"><br>
            </td>
            <td style="width: 3.48%; vertical-align: top; font-size: 10pt;">By:</td>
            <td style="width: 47%; vertical-align: top; border-bottom: 2px solid black; font-size: 10pt;">
              <div style="text-align: justify; font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';">/s/ Kevin Siebert</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;"><br>
            </td>
            <td style="width: 3.48%; vertical-align: top; font-size: 10pt;"><br>
            </td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: justify; font-family: 'Times New Roman';">Name: Kevin Siebert</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;"><br>
            </td>
            <td style="width: 3.48%; vertical-align: top; font-size: 10pt;"><br>
            </td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Title: Senior Vice President, General Counsel <br>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
            <td style="width: 3.48%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt;" rowspan="1">and Secretary</td>
          </tr>

      </table>
      <div style="font-size: 10pt;">
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 12pt;"> <br>
        </div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">[<font style="font-family: 'Times New Roman'; font-style: italic;">Signature page to Underwriting Agreement</font>]</div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
        </div>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="zcae620cdb9c24296b63303278e2e39c0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="vertical-align: top; font-size: 10pt;" colspan="3" rowspan="1">
              <div style="text-align: justify; font-family: 'Times New Roman';">Accepted as of the date hereof:</div>
            </td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;"><br>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt;" colspan="3" rowspan="1"><br>
            </td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;"><br>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt;" colspan="3" rowspan="1">
              <div style="text-align: justify; font-family: 'Times New Roman';">STIFEL, NICOLAUS &amp; COMPANY, INCORPORATED</div>
            </td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;"><br>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt;" colspan="3" rowspan="1"><br>
            </td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;" colspan="1">By:</td>
            <td style="vertical-align: top; border-bottom: 2px solid black; font-size: 10pt;" rowspan="1" colspan="2">
              <div style="text-align: justify; font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';">/s/ Lewis Chia</font></div>
            </td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;" colspan="1"><br>
            </td>
            <td style="width: 2%; vertical-align: top; font-size: 10pt;"><br>
            </td>
            <td style="width: 45%; vertical-align: top; font-size: 10pt;" colspan="1">
              <div style="text-align: justify; font-family: 'Times New Roman';">Name: Lewis Chia</div>
            </td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;" colspan="1"><br>
            </td>
            <td style="width: 2%; vertical-align: top; font-size: 10pt;"><br>
            </td>
            <td style="width: 45%; vertical-align: top; font-size: 10pt;" colspan="1">
              <div style="text-align: justify; font-family: 'Times New Roman';">Title: Managing Director</div>
            </td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;"><br>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">For themselves and as Representatives of the</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">other Underwriters named in Schedule I hereto</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">[<font style="font-family: 'Times New Roman'; font-style: italic;">Signature page to Underwriting Agreement</font>]</div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
        </div>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="z9ccbf89a31b84309b8fdac551821da7c" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="vertical-align: top; font-size: 10pt;" colspan="3" rowspan="1">
              <div style="text-align: justify; font-family: 'Times New Roman';">Accepted as of the date hereof:</div>
            </td>
            <td style="vertical-align: top; font-size: 10pt; width: 50%;" colspan="1" rowspan="1"><br>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt;" colspan="3" rowspan="1"><br>
            </td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;" colspan="1" rowspan="1"><br>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt;" colspan="3" rowspan="1">
              <div style="text-align: justify; font-family: 'Times New Roman';">NEEDHAM &amp; COMPANY, LLC</div>
            </td>
            <td style="vertical-align: top; font-size: 10pt; width: 50%;" colspan="1" rowspan="1"><br>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt;" colspan="3" rowspan="1"><br>
            </td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;" colspan="1" rowspan="1"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;" colspan="1">By:</td>
            <td style="width: 2%; vertical-align: top; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1" colspan="2">
              <div style="text-align: justify; font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';">/s/ Matthew Castrovince</font></div>
            </td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;" rowspan="1" colspan="1"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;" colspan="1"><br>
            </td>
            <td style="width: 2%; vertical-align: top; font-size: 10pt;" colspan="1"><br>
            </td>
            <td style="width: 45%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: justify; font-family: 'Times New Roman';">Name: Matthew Castrovince</div>
            </td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;" colspan="1"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;" colspan="1"><br>
            </td>
            <td style="width: 2%; vertical-align: top; font-size: 10pt;" colspan="1"><br>
            </td>
            <td style="width: 45%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: justify; font-family: 'Times New Roman';">Title: Managing Director</div>
            </td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;" colspan="1"><br>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">For themselves and as Representatives of the</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">other Underwriters named in Schedule I hereto</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">SCHEDULE I</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="za95e5e992ae04bddb9b8a6baf7e9cbd1" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="width: 35%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 15%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; font-family: 'Times New Roman';"><u>Number of Firm Shares</u></div>
            </td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 35%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: justify; font-family: 'Times New Roman';"><u>Underwriter</u></div>
            </td>
            <td style="width: 15%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; font-family: 'Times New Roman';"><u>to be Purchased</u></div>
            </td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 35%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 35%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">Stifel, Nicolaus &amp; Company, Incorporated</div>
            </td>
            <td colspan="2" style="vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">3,333,333</div>
            </td>
          </tr>
          <tr>
            <td style="width: 35%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 35%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">Needham &amp; Company, LLC</div>
            </td>
            <td colspan="2" style="vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">2,666,667</div>
            </td>
          </tr>
          <tr>
            <td style="width: 35%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 35%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">UBS Securities LLC</div>
            </td>
            <td colspan="2" style="vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">2,000,000</div>
            </td>
          </tr>
          <tr>
            <td style="width: 35%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 35%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">B. Riley Securities, Inc.</div>
            </td>
            <td colspan="2" style="vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">888,889</div>
            </td>
          </tr>
          <tr>
            <td style="width: 35%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 35%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">Northland Securities, Inc.</div>
            </td>
            <td colspan="2" style="vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">888,889</div>
            </td>
          </tr>
          <tr>
            <td style="width: 35%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 35%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">Rosenblatt Securities Inc.</div>
            </td>
            <td colspan="2" style="vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman';">888,889</div>
            </td>
          </tr>
          <tr>
            <td style="width: 35%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 35%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: justify; font-family: 'Times New Roman';">BMO Capital Markets Corp.</div>
            </td>
            <td colspan="2" style="vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: justify; font-family: 'Times New Roman';">444,444</div>
            </td>
          </tr>
          <tr>
            <td style="width: 35%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 35%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: justify; font-family: 'Times New Roman'; margin-left: 9pt;">Total:</div>
            </td>
            <td colspan="2" style="vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: justify; font-family: 'Times New Roman';">11,111,111</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">SCHEDULE II</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Free Writing Prospectuses, Written Testing-the-Waters Communications and Other Documents</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Investor Presentation dated May 2026.</div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';"><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">SCHEDULE III</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Pricing Information</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Public Offering Price: $45.00 per share</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Number of Firm Shares: 11,111,111</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Number of Option Shares: 1,666,666</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Underwriting Discounts and Commissions: $1.35 per share</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">EXHIBIT A</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">FORM OF LOCK-UP AGREEMENT</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">VIAVI SOLUTIONS INC.</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">1445 South Spectrum Blvd, Suite 102</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Chandler, Arizona 85286</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">STIFEL, NICOLAUS &amp; COMPANY, INCORPORATED</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">NEEDHAM &amp; COMPANY, LLC</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 36pt;">c/o Stifel, Nicolaus &amp; Company, Incorporated</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 36pt;">1201 Wills Street, 6<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> Floor</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 36pt;">Baltimore, Maryland 21231</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 36pt;">c/o Needham &amp; Company, LLC</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 36pt;">250 Park Avenue, 10th Floor</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 36pt;">New York, NY 10177</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Ladies and Gentlemen:</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The undersigned refers to the proposed Underwriting Agreement (the &#8220;Underwriting Agreement&#8221;) among Viavi Solutions Inc., a Delaware corporation (the
        &#8220;Company&#8221;), Stifel, Nicolaus &amp; Company, Incorporated and Needham &amp; Company, LLC, as representatives (the &#8220;Representatives&#8221;) of the several underwriters named therein (collectively, the &#8220;Underwriters&#8221;). As an inducement to the
        Representatives to execute the Underwriting Agreement in connection with the proposed public offering (the &#8220;Offering&#8221;) of shares of the Company&#8217;s common stock, par value $0.001 per share (&#8220;Common Stock&#8221;), pursuant to a Registration Statement on
        Form S-3 (the &#8220;Registration Statement&#8221;), including the prospectus contained therein (such prospectus, in the form used to confirm sales of Common Stock in the Offering, the &#8220;<a name="z_9kR3WTr266457XV135sgwFF"></a>Prospectus&#8221;), and in light of the
        benefits that the Offering will confer upon the undersigned in his, her, or its capacity as a securityholder and/or an officer, director or employee of the Company, the undersigned hereby agrees that from the date hereof and until 60 days after the
        public offering date set forth on the <a name="z_9kMHG5YVt488679ZX357uiyHH"></a>Prospectus (such 60 day period being referred to herein as the &#8220;Lock-Up Period&#8221;), the undersigned will not (and will use best efforts to cause any spouse or immediate
        family member of the spouse or the undersigned living in the undersigned&#8217;s household, any partnership, corporation or other entity within the undersigned&#8217;s control, and any trustee of any trust that holds Common Stock or other securities of the
        Company for the benefit of the undersigned or such spouse or immediate family member living in the undersigned&#8217;s household not to) offer, sell, assign, contract to sell (including any short sale), pledge, hypothecate, establish an open &#8220;put
        equivalent position&#8221; within the meaning of Rule 16a-1(h) under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), grant any option, right or warrant for the sale of, purchase any option or contract to sell, sell any option,
        right, warrant or contract to purchase, lend, or otherwise encumber, dispose of or transfer, or grant any rights with respect to, directly or indirectly, any of the Undersigned&#8217;s Shares, enter into a transaction which would have the same effect, or
        enter into any swap, hedge or other arrangement that transfers, in whole or in part, any of the economic consequences of ownership of the Common Stock, whether any such aforementioned transaction is to be settled by delivery of the Common Stock or
        such other securities, in cash or otherwise, or publicly disclose the intention to make any such offer, sale, pledge or disposition, or to enter into any such transaction, swap, hedge or other arrangement, except as provided herein. As used in this
        letter agreement, the &#8220;Undersigned&#8217;s Shares&#8221; means any shares of Common Stock of the Company, or any options or warrants to purchase any shares of Common Stock of the Company, or any securities convertible into, exchangeable for or that represent
        the right to receive shares of Common Stock of the Company, whether now owned or hereinafter acquired, owned directly by the undersigned (including holding as a custodian) or with respect to which the undersigned has beneficial ownership within the
        rules and regulations of the U.S. Securities and Exchange Commission.</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%%%-->
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Notwithstanding the foregoing, the undersigned may,</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">(a) transfer the Undersigned&#8217;s Shares:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z13dd1d645bc44795a3f84d5b7f49b57d" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(i)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">as a bona fide gift or charitable contribution;</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zc92a80cd34794478b5a2c723bf9015f2" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(ii)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">to the Underwriters pursuant to the Underwriting Agreement (including upon the exercise of options);</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z7ebf295c0bcf4424b9490eec5f6a92cb" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(iii)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">to an immediate family member or a trust for the direct or indirect benefit of the undersigned or such immediate family member of the undersigned;</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z33b09bacd9f14a369d38e04651d3cdc4" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(iv)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">by will or intestacy;</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zfa84807523ee42adaed50c2ff376c2a5" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(v)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">pursuant to a domestic relations order, divorce decree or court order;</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zaf19c20a08334bc1bcb0f653af3e2833" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(vi)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">to limited partners, general partners, members, stockholders or holders of similar equity interests, or <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">other business entity
                  that controls, is controlled by or managed by or is under common control with the undersigned;</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z193ad1f5d06140ce9d03f1f167b852da" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(vii)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">if the undersigned is a trust, to a trustor or beneficiary of the trust or to the estate of a beneficiary of such trust;</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zc8765de6b3ee402ebe63554b2fc6ebe7" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(viii)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">to the Company in connection with the repurchase of the Undersigned&#8217;s Shares in connection with the termination of the undersigned&#8217;s employment with the Company pursuant to contractual agreements
                with the Company;</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">2</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z2e4c1b5a8f194a62b982860ebef01406" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(ix)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">to the Company upon the vesting of restricted stock, restricted stock units, restricted stock awards or other incentive awards settled in shares of Common Stock or upon the exercise of options to
                purchase Common Stock on a &#8220;cashless exercise&#8221; or &#8220;net exercise&#8221; basis to the extent permitted by the instruments representing such options so long as such &#8220;cashless exercise&#8221; or &#8220;net exercise&#8221; is effected solely by the surrender of
                outstanding Company securities or options to the Company and the Company&#8217;s cancellation of all or a portion thereof to pay the exercise price and/or income, employment or tax withholding and remittance obligations, but for the avoidance of
                doubt, excluding all methods of exercise of options that would involve a sale of any shares of Common Stock relating to such options, whether to cover the applicable exercise price, income, employment or tax withholding and remittance
                obligations or otherwise; <font style="font-family: 'Times New Roman'; font-style: italic;">provided</font> that such restricted stock, restricted stock units, restricted stock awards, other incentive awards or options were granted under
                an equity incentive plan, stock purchase plan or pursuant to a contractual employment arrangement described in the <a name="z_9kMIH5YVt488679ZX357uiyHH"></a>Prospectus (including the documents and exhibits incorporated by reference
                therein) and were outstanding as of the date of the <a name="z_9kMJI5YVt488679ZX357uiyHH"></a>Prospectus; <font style="font-family: 'Times New Roman'; font-style: italic;">provided, further</font>, <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">that no public filing, report or announcement shall be voluntarily made and, if required, any public filing, report or announcement, including under Section 16(a) of the Exchange Act, shall clearly indicate
                  in the footnotes thereto </font>the nature and conditions of such transfer;</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z9cd446948b924d1db8866591db2d3e58" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(x)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">through the exercise of a stock option granted under an equity incentive plan or stock purchase plan described in the <a name="z_9kMML5YVt488679ZX357uiyHH"></a>Prospectus (including the documents
                and exhibits incorporated by reference therein) by the undersigned, and the receipt by the undersigned from the Company of shares of Common Stock upon such exercise, insofar as such option is outstanding as of the date of the <a name="z_9kMNM5YVt488679ZX357uiyHH"></a>Prospectus; <font style="font-family: 'Times New Roman'; font-style: italic;">provided</font> that <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">no public filing, report or
                  announcement shall be voluntarily made and, if required, any public filing, report or announcement, including under Section 16(a) of the Exchange Act, shall clearly indicate in the footnotes thereto </font>the nature and conditions of
                such transfer;</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z8663f39818704122bf220c9cbcd3ce1a" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(xi)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">pursuant to a </font><font style="font-size: 10pt;">merger, consolidation or other similar
                  transaction involving a Change of Control of the Company and approved by the Company&#8217;s board of directors; <font style="font-family: 'Times New Roman'; font-style: italic;">provided</font> that, in the event that such Change of Control
                  transaction is not completed, this clause (a)(xi) shall not be applicable and the Undersigned&#8217;s Shares shall remain subject to the restrictions contained in this letter agreement. &#8220;Change of Control&#8221; shall mean the transfer (whether by
                  tender offer, merger, consolidation or other similar transaction), in one transaction or a series of related transactions, to a person or group of affiliated persons (other than an Underwriter pursuant to the Offering), of the Company&#8217;s
                  voting securities if, after such transfer, such person or group of affiliated persons would hold at least 50% of the outstanding voting securities of the Company (or the surviving entity) and for the avoidance of doubt, the Offering is
                  not a Change of Control; or</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z000783df6d2c46e9baa1ae67f127cf20" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(xii)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">with the prior written consent of </font><font style="font-size: 10pt;">Stifel, Nicolaus &amp;
                  Company, Incorporated, which consent may be withheld in its sole discretion.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">3</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">(b) establish a trading plan pursuant to Rule 10b5&#8209;1 under the Exchange Act for the transfer of the Undersigned&#8217;s Shares, <font style="font-family: 'Times New Roman'; font-style: italic;">provided</font> that such plan does not provide for the transfer of the Undersigned&#8217;s Shares during the Lock-Up Period; or</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">(c) sell the Undersigned&#8217;s Shares in the amounts provided to the Representatives in writing prior to the date hereof pursuant to a plan, contract or instruction that
        satisfies all of the requirements of Rule 10b5-1(c)(1)(i)(B) that was in effect prior to the date hereof; <font style="font-family: 'Times New Roman'; font-style: italic;">provided</font> that <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">any filing under Section 16(a) of the Exchange Act or other public filing or announcement made during the Lock-Up Period shall indicate that such sales were made pursuant to a 10b5-1 plan</font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In addition, in the case of clauses (a)(i) and (iii)-(vii) above, it shall be a condition to such transfer that each transferee, donee or
        distributee <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">executes and delivers to </font>Stifel, Nicolaus &amp; Company, Incorporated<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> a letter agreement in
          substantially the form of this letter agreement; and, </font><font style="font-family: 'Times New Roman'; font-style: italic; color: rgb(0, 0, 0);">provided, further</font><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> that
          in the case of clauses (a)(iii)-(viii) above, no filing under Section 16(a) of the Exchange Act or other public announcement shall be required or shall be voluntarily made during the Lock-Up Period. To the extent any such transfers are made
          pursuant to clauses (a)(i)-(xii) above, any of the Undersigned&#8217;s Shares retained by the undersigned (or the undersigned&#8217;s spouse or immediate family member living in the undersigned&#8217;s household) following such transfer shall remain subject to the
          restrictions contained in this letter agreement.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">For purposes of this letter agreement, &#8220;immediate family&#8221; shall mean any child, stepchild, grandchild, parent, stepparent, grandparent, spouse,
        sibling, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law, and shall include adoptive relationships.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In addition, the undersigned agrees that, during the Lock-Up Period, without the prior written consent of Stifel, Nicolaus &amp; Company,
        Incorporated (which consent may be withheld in its sole discretion), the undersigned will not request, make any demand for or exercise any right with respect to, the registration of any Common Stock or any security convertible into or exercisable
        or exchangeable for Common Stock.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In furtherance of the foregoing, the Company and its transfer agent and registrar are hereby authorized to (i) decline to make any transfer of the
        Undersigned&#8217;s Shares if such transfer would constitute a violation or breach of this letter agreement and (ii) place legends and stop transfer instructions on the Undersigned&#8217;s Shares.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The undersigned hereby represents and warrants that the undersigned has full power and authority to enter into this letter
        agreement and that this letter agreement has been duly authorized (if the undersigned is not a natural person), executed and delivered by the undersigned and is a valid and binding agreement of the undersigned.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">The undersigned and </font><font style="font-size: 10pt;">Stifel,




          Nicolaus &amp; Company, Incorporated <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">hereby consent to receipt of this letter agreement in electronic form and understand and agree that this letter agreement may be signed
            electronically. In the event that any signature is delivered by facsimile transmission, electronic mail, or otherwise by electronic transmission evidencing an intent to sign this letter agreement </font>(including any electronic signature
          complying with the U.S. federal ESIGN Act of 2000, <font style="font-family: 'Times New Roman'; font-style: italic;">e.g.</font>, www.docusign.com)<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">, such facsimile transmission,
            electronic mail or other electronic transmission and any counterpart so delivered shall create a valid and binding obligation of the undersigned with the same force and effect as if such signature were an original. Execution and delivery of
            this letter agreement by facsimile transmission, electronic mail or other electronic transmission is legal, valid and binding for all purposes.</font></font></div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> <br>
          </font></font></div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">4</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">This letter agreement is irrevocable and shall be binding on the undersigned and the successors, heirs, personal representatives and assigns of the
        undersigned. This letter agreement shall be governed by and construed in accordance with the laws of the State of New York, without regard to choice of law rules. This letter agreement shall automatically terminate and the undersigned will be
        released from all of his, her or its obligations hereunder upon the earliest to occur, if any, of (i) prior to the execution of the Underwriting Agreement, the Company advises the Representatives in writing that it has determined not to proceed
        with the Offering, (ii) the Company files an application to withdraw the Registration Statement, (iii) the Underwriting Agreement is executed but is terminated (other than the provisions thereof which survive termination) prior to payment for and
        delivery of the Common Stock to be sold thereunder, or (iv) June 15, 2026, in the event the Underwriting Agreement has not been executed by such date.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">This letter agreement constitutes the entire agreement between the parties hereto with respect to the subject matter hereof and supersedes all prior
        agreements and understandings, oral, written and implied, between the parties hereto with respect to the subject matter hereof.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">(Signature Page Follows)</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"> <br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal;"><a name="z_Hlk219115820"></a></div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">5</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="z682ea57c5f1f43cb8f54511a72dd1dd0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td rowspan="1" style="width: 50%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>
            <td rowspan="1" style="width: 3%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>
            <td rowspan="1" style="width: 47%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: justify; font-family: 'Times New Roman';">Very truly yours,</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt;"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;" colspan="1">&#160;</td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;" colspan="1">&#160;</td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a name="z_DV_M46"></a>Name of <a name="z_9kR3WTr266458bLct9y1IhS3tn2"></a>Security Holder <font style="font-family: 'Times New Roman'; font-style: italic;">(</font><a name="z_9kR3WTr266459ZVvs4"></a><font style="font-family: 'Times New Roman'; font-style: italic;">Print exact name</font>)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt;"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;" colspan="1">&#160;</td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;" colspan="1">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">By:</div>
            </td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a name="z_DV_M48"></a>Signature<a name="z_DV_M651"></a><a name="z_DV_M49"></a></div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt;"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">If not signing in an individual capacity:</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt;"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;" colspan="1">&#160;</td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;" colspan="1">&#160;</td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><br>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a name="z_DV_M51"></a>Name of Authorized Signatory <font style="font-family: 'Times New Roman'; font-style: italic;">(Print</font>)<a name="z_DV_M652"></a><a name="z_DV_M52"></a></div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;" colspan="1">&#160;</td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;" colspan="1">&#160;</td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><br>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a name="z_DV_M53"></a>Title of Authorized Signatory <font style="font-family: 'Times New Roman'; font-style: italic;">(Print</font>)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt;"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic;">(indicate capacity of person signing if signing as <br>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt;">custodian, trustee, or on behalf of an entity)</td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="font-size: 10pt;">
        <hr noshade="noshade" align="center" style="height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); text-align: center; margin-left: auto; margin-right: auto; border: medium none;"></div>
    </div>
  </div>
  <font style="font-size: 10pt;"> </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>ef20074430_ex5-1.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 26.3.2.5342
         Copyright 1995 - 2026 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <font style="font-size: 10pt;"> </font>
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div style="font-size: 10pt; text-align: right;"><font style="font-weight: bold;">Exhibit 5.1</font><br>
    </div>
    <div style="font-size: 10pt; text-align: left;"> <br>
    </div>
    <div style="font-size: 10pt; text-align: left;"><img src="image00001.jpg"> </div>
    <div> <font style="font-size: 10pt;"><br>
      </font></div>
    <div>
      <div style="text-align: right; font-size: 10pt;"><a name="z_mps386743290000000000000003039000000000"></a><a name="z_Hlk96687833"></a><font style="font-family: 'Times New Roman';">Client: 94846-00027</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">May 21, 2026</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><a name="z_mpv268469640000030000000000000000000000"></a><a name="z_mpd395058350000000000000000000000000000"></a><a name="z_mpu274504300000000000000000000000000000"></a>Viavi

        Solutions Inc.</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><a name="z_mpu370636280000000000000000000000000000"></a>1445 South Spectrum Blvd, Suite 102</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Chandler, Arizona 85286</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" id="zf66ce6c3fc9b432baaf6dc7fa9376ed3" class="DSPFListTable">

            <tr style="vertical-align: top;">
              <td style="text-align: right; vertical-align: top; width: 36pt;">
                <div style="text-align: left; font-size: 10pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Re:</font></div>
              </td>
              <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: left; font-size: 10pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Viavi Solutions Inc.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" class="DSPFListTable">

              <tr style="vertical-align: top;">
                <td style="text-align: right; vertical-align: top; width: 36pt;"><br>
                </td>
                <td style="text-align: left; vertical-align: top; width: auto;">
                  <div style="text-align: left; font-size: 10pt;">
                    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">
                      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Registration Statement on Form S-3 (File No. 333-289490)</div>
                    </div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
        <div> <br>
        </div>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><a name="z_mpv065469010000060000000000000000000000"></a>Ladies and Gentlemen:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">We have examined the Registration Statement on Form S-3, File No. 333-289490 (the &#8220;<font style="font-family: 'Times New Roman';"><u>Registration Statement</u></font>&#8221;),
        of Viavi Solutions Inc., a Delaware corporation (the &#8220;<font style="font-family: 'Times New Roman';"><u>Company</u></font>&#8221;), filed with the Securities and Exchange Commission (the &#8220;<font style="font-family: 'Times New Roman';"><u>Commission</u></font>&#8221;)

        pursuant to the Securities Act of 1933, as amended (the &#8220;<font style="font-family: 'Times New Roman';"><u>Securities Act</u></font>&#8221;), and the prospectus supplement thereto dated May 19, 2026 (the &#8220;<font style="font-family: 'Times New Roman';"><u>Prospectus

            Supplement</u></font>&#8221;), in connection with the offering by the Company of up to 12,777,777 shares of the Company&#8217;s common stock (the &#8220;<font style="font-family: 'Times New Roman';"><u>Common Stock</u></font>&#8221;), par value $0.001 per share (the &#8220;<font style="font-family: 'Times New Roman';"><u>Shares</u></font>&#8221;).&#160; The Shares are being sold pursuant to an underwriting agreement, dated May 19, 2026, among the Company and the representatives of the underwriters named therein.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">In arriving at the opinion expressed below, we have examined originals, or copies certified or otherwise identified to our satisfaction<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> as being true and complete copies of the originals</font>, of such documents, corporate records, certificates of officers of the Company and of public officials and other instruments as we have deemed necessary
        or advisable to enable us to render the opinions set forth below.&#160; In our examination, we have assumed without independent investigation the genuineness of all signatures, the legal capacity and competency of all natural persons, the authenticity
        of all documents submitted to us as originals and the conformity to original documents of all documents submitted to us as copies.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Based upon the foregoing, and subject to the assumptions, exceptions, qualifications and limitations set forth herein, we are of the opinion that the Shares, when issued
        against payment therefor as set forth in the Registration Statement, will be validly issued, fully paid and non-assessable.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">We consent to the filing of this opinion as an exhibit to the Registration Statement, and we further consent to the use of our name under the caption &#8220;<font style="font-family: 'Times New Roman';"><u>Legal Matters</u></font>&#8221; in the Registration Statement and the Prospectus Supplement.&#160; In giving these consents, we do not thereby admit that we are within the category of persons whose consent is
        required under Section 7 of the Securities Act or the Rules and Regulations of the Commission.</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 8pt;"><a name="z_mps617902360000000000000008653000000000"></a><a name="z_mpv472654410000010000000000000000000000"></a></div>
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
        </div>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="width: 100%;" class="BRPFPageFooter">
          <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 8pt;"><font style="font-size: 8pt; font-family: 'Times New Roman'; font-weight: bold;">Gibson, Dunn &amp; Crutcher LLP</font><font style="font-size: 8pt; font-family: 'Times New Roman';"><br>
              </font><font style="font-size: 8pt;">310 University Avenue, 3rd Floor&#160; |&#160; Palo Alto, CA 94301&#160; |&#160; T: 650.849.5300&#160; |&#160; gibsondunn.com</font></div>
          </div>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div> <img src="image00001.jpg">
        <div><br>
        </div>
        <div style="text-align: right; font-size: 10pt;">
          <div style="font-family: 'Times New Roman';">May 21, 2026<font style="font-family: 'Times New Roman';"><br>
            </font>Page 2</div>
        </div>
        <div><br>
        </div>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="z8e74e22dcd6741b59c190a13607e5428" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><a name="z_mps141819380000000000000002038000000000"></a><a name="z_mps156660550000000000000000965000000000"></a><a name="z_mpv443359660000000000000000000000000000"></a>Very truly yours,</div>
            </td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;" rowspan="1">&#160;</td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;" rowspan="1">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">/S/ GIBSON, DUNN &amp; CRUTCHER LLP</div>
            </td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>
          </tr>

      </table>
      <div style="font-size: 10pt; font-family: 'Times New Roman';"><br>
      </div>
      <div style="font-size: 10pt; font-family: 'Times New Roman';"><br>
      </div>
      <div style="text-align: left; font-size: 10pt;"><a name="z_mpd848162300000000000000000000000000000"></a><a name="z_mpd416690110000000000000000000000000000"></a>
        <div>
          <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
      </div>
    </div>
  </div>
  <font style="font-size: 10pt;"> </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>viav-20260519.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 26.3.2.5342 Broadridge-->
<xs:schema targetNamespace="http://viavisolutions.com/20260519" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:viav="http://viavisolutions.com/20260519" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:srt-types="http://fasb.org/srt-types/2025">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="viav-20260519_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="viav-20260519_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://viavisolutions.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2025" schemaLocation="https://xbrl.sec.gov/currency/2025/currency-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2025" schemaLocation="https://xbrl.sec.gov/exch/2025/exch-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2025" schemaLocation="https://xbrl.sec.gov/naics/2025/naics-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2025" schemaLocation="https://xbrl.sec.gov/sic/2025/sic-2025.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2025" schemaLocation="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>viav-20260519_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 26.3.2.5342 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract" xml:lang="en-US" id="dei_CoverAbstract">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract" xlink:title="label: CoverAbstract to dei_CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType" xml:lang="en-US" id="dei_DocumentType">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType" xlink:title="label: DocumentType to dei_DocumentType" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications" xml:lang="en-US" id="dei_WrittenCommunications">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications" xlink:title="label: WrittenCommunications to dei_WrittenCommunications" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial" xml:lang="en-US" id="dei_SolicitingMaterial">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer" xml:lang="en-US" id="dei_PreCommencementTenderOffer">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag" xml:lang="en-US" id="dei_AmendmentFlag">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag" xlink:title="label: AmendmentFlag to dei_AmendmentFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus" xml:lang="en-US" id="dei_DocumentFiscalYearFocus">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate" xml:lang="en-US" id="dei_DocumentPeriodEndDate">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName" xml:lang="en-US" id="dei_EntityRegistrantName">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey" xml:lang="en-US" id="dei_EntityCentralIndexKey">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber" xml:lang="en-US" id="dei_EntityFileNumber">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber" xlink:title="label: EntityFileNumber to dei_EntityFileNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1" xml:lang="en-US" id="dei_EntityAddressAddressLine1">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2" xml:lang="en-US" id="dei_EntityAddressAddressLine2">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3" xml:lang="en-US" id="dei_EntityAddressAddressLine3">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown" xml:lang="en-US" id="dei_EntityAddressCityOrTown">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince" xml:lang="en-US" id="dei_EntityAddressStateOrProvince">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry" xml:lang="en-US" id="dei_EntityAddressCountry">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode" xml:lang="en-US" id="dei_EntityAddressPostalZipCode">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode" xml:lang="en-US" id="dei_CityAreaCode">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode" xlink:title="label: CityAreaCode to dei_CityAreaCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber" xml:lang="en-US" id="dei_LocalPhoneNumber">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle" xml:lang="en-US" id="dei_Security12bTitle">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle" xlink:title="label: Security12bTitle to dei_Security12bTitle" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag" xml:lang="en-US" id="dei_NoTradingSymbolFlag">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol" xml:lang="en-US" id="dei_TradingSymbol">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol" xlink:title="label: TradingSymbol to dei_TradingSymbol" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName" xml:lang="en-US" id="dei_SecurityExchangeName">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>viav-20260519_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 26.3.2.5342 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://viavisolutions.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="viav-20260519.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://viavisolutions.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: CoverAbstract to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalYearFocus" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalPeriodFocus" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFileNumber" xlink:title="presentation: CoverAbstract to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: CoverAbstract to EntityIncorporationStateCountryCode" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: CoverAbstract to EntityTaxIdentificationNumber" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine1" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine2" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine3" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: CoverAbstract to EntityAddressCityOrTown" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: CoverAbstract to EntityAddressStateOrProvince" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCountry" xlink:title="presentation: CoverAbstract to EntityAddressCountry" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: CoverAbstract to EntityAddressPostalZipCode" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CityAreaCode" xlink:title="presentation: CoverAbstract to CityAreaCode" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="LocalPhoneNumber" xlink:title="presentation: CoverAbstract to LocalPhoneNumber" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="Security12bTitle" xlink:title="presentation: CoverAbstract to Security12bTitle" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="TradingSymbol" xlink:title="presentation: CoverAbstract to TradingSymbol" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: CoverAbstract to NoTradingSymbolFlag" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SecurityExchangeName" xlink:title="presentation: CoverAbstract to SecurityExchangeName" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="WrittenCommunications" xlink:title="presentation: CoverAbstract to WrittenCommunications" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SolicitingMaterial" xlink:title="presentation: CoverAbstract to SolicitingMaterial" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementTenderOffer" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementIssuerTenderOffer" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image00001.jpg
<TEXT>
begin 644 image00001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  5 +@# 2(  A$! Q$!_\0
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'H0<N5;G_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>May 19, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 19,  2026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-22874<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">VIAVI SOLUTIONS INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000912093<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">94-2579683<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1445 South Spectrum Blvd<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 102<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Chandler<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">AZ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">85286<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">408<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">404-3600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value of $0.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">VIAV<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ef20074430_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://viavisolutions.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ef20074430_8k.htm">ef20074430_8k.htm</File>
    <File>viav-20260519.xsd</File>
    <File>viav-20260519_lab.xml</File>
    <File>viav-20260519_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ef20074430_8k.htm": {
   "nsprefix": "viav",
   "nsuri": "http://viavisolutions.com/20260519",
   "dts": {
    "inline": {
     "local": [
      "ef20074430_8k.htm"
     ]
    },
    "schema": {
     "local": [
      "viav-20260519.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/currency/2025/currency-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/exch/2025/exch-2025.xsd",
      "https://xbrl.sec.gov/naics/2025/naics-2025.xsd",
      "https://xbrl.sec.gov/sic/2025/sic-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "viav-20260519_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "viav-20260519_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 29,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 23
   },
   "report": {
    "R1": {
     "role": "http://viavisolutions.com/role/DocumentAndEntityInformation",
     "longName": "000100 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c20260519to20260519",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20074430_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20260519to20260519",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20074430_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://viavisolutions.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://viavisolutions.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://viavisolutions.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://viavisolutions.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://viavisolutions.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://viavisolutions.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://viavisolutions.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://viavisolutions.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://viavisolutions.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://viavisolutions.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://viavisolutions.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://viavisolutions.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://viavisolutions.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://viavisolutions.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://viavisolutions.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://viavisolutions.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://viavisolutions.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://viavisolutions.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://viavisolutions.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://viavisolutions.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://viavisolutions.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://viavisolutions.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://viavisolutions.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://viavisolutions.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://viavisolutions.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://viavisolutions.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://viavisolutions.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://viavisolutions.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001140361-26-022337-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-26-022337-xbrl.zip
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M95B;);?(K4[.04FXX*546;W? P5WY'HSS@!O/EB3$_%QW*J M![";@",->\
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M5IID[J084WYW0(3J%P$ > U@^29E[-$<>P4GE &J1W0QLG!G^HGG<O^07'G
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M__$5+&V7-V[D%SDNPW?)X\6GWAB2LVSR\;RIE]7T(/Z3G0 _\EDRSYKSHCK
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MU8=Y+3%EZL. 4X0+XXN:)<8'P1RM?$-A[](&ORJH\D)=45=H/N!KT@Y:7Y/
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M4G;\=$'*X^I5S/,3(N+[B+;X&X2U,\5NO <NIHSC& '>VC>YE%XK#"H*5D7
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MWH;1^KY=D*X,NH^;;$10C;3MF!8FNK(\=S76S"2+L7+%'RH+J+5";2@A[$*
M[QNJ-R=D?M(5'2M*D,H(2D"Y??M>5TR.3>0VC"$T(H?JR<N22L7;H%9<DUHS
M"MI)$)FQ$M=VPX:BLHK;R]R2ZP1Z &YF?\3ONTH_^JI;#AII_! ?Y?'AQ&6;
M*YAA2E]7.KXS^7WOT</.B]] !@,RVZ/=(?SMV;(HF=S_(B\56,;Z=]-CHQ5
MA\0_@N0E9<(3(1Q!R<( S(3+-IDH FOAV^5<X5IQ_1]-5"@E%-F*^0KPA[A>
M7D.IJ?D\"X)BYYA<L#.PL5WM1 ]*U-]QO[P;-^E^:>EMU?2M@K^_!O&RN#9_
MVR3JF [VQ)0EW+AESW:SG3%<<XY;V2?P"6^?>$6Z=2EUP=D.@8X/1$ I2V+*
MC 5!R52VT4N"X-)J>X.$C!&*)BCE"ASWU?7@RQ1<Y,=)+Q5Z(XRM&$ $#T"
MH]#W!CQPW9AH3<26O2MNH%YEO\2Q1X*NCJ T=67 5MYPH*:Q2AQ8B1G!0I]#
MR),$,7PFYOK-22[OH ;:$<'(+:A%A@RWR&2JJ8Z1+^<F'RM_YV;T+5+E3,
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MQ.KA)-FHZ/_0PW(+#IIKQZ>'.WMN1S7(B4&53.;ZI.@O$WWYO&'J2N +3,&
M'37AE[5Z72.$@WA@V//2OE;\T0/Z+1&EZ1<.5/*&:>*1M6' 8;'4WGQB)3*)
M1@&5%Y"_U0=A41' .9<?=/H%"VTWE=FP=MKI%-=!+":AD_.5^P&,P_Y!QH2<
M8X@[X:05E3=*7SII(D&T*]*787VLBS:+$6A8)I\W8F ;HKNVRQ>M<"1VO<:
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M[IL[^%K2>T'GG!:KRI%; &%N_3-\\ABSV0.DIR,SHI=A*9;"T9 %!Z[MHB-
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M6@[9D.<Q$">*X0#Q82(UY*C(WQDJ<E52P>$>#M7$$>HU\>^8DU8#)V'943'
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MU; .'UYQOLR($:X?R!;S\+V2 0I29J7@<*4$H)K$27U>@:1-R>K%=!>RL\L
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MVXH,39,H0"W4.:XU'5)=?%J8$"<=)?2.@H3XZ%N9EB'CN*$$QX0U '^;%4W
M3:S/A!_A2LO.18?X2P7,BH(5I>5ADD57P2*T PZ4#29P47J<<[8,*ZKIM'<E
M(0>+*2<66V*0H4#(HF'R\D#3W$(O#ZI!'W%U&CAE/+84I=$!W$#HCI 9??_O
MR^FY:8*SGGVFK<VNHB<H.\L-B@GJCZUKY[:;$%V]A"_40B>)-1HT#],Q>:9V
M/CTC\)>SG#!PCIPQ$RQ\[%QL[5A(K)'033'UE=LGZ;URZRU\B#[>P^CCHX?H
MXYV*/N9?DM3LPT6_VF0LUN9Z0.TXU&=AC_3$JUIC.)>$YBTFANK)8U:TW1A>
M:G2_@,."&4U%224?J_J*FLA@4Y!E-VCE^)L9+@O&4D942GTCJ\^K%%![H_4?
MT'M+_KE-OL'$*/7-4S?%<TLZ4R0* :<F_IO&T4T;V0R6A]&#W^Q-]E.QN3+$
M4%7.ZP4K9"E&13#6_@7<,[,UG?X-YKU-=LN$MZ;2M()>NJ-\K"M,-\E 63V_
MT;&0!-G"MI\NM(E"*:<GKQF-=QEH-/_H6NWG$>]-'&CVI6O<?QT&*(6:)=R>
M<37S<W'6$I)@657)OV?SQ;/D>;/L)F@ OW[]-NW!T9T,&1$/*$P'5 '^KFC
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M9;K%D1(2K[MUL';3]#4\9+L\7A%QWD8A?ILMR^0O6<NE"8-65EC&=AM3JU[
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MSGU*,[:8$]VCJ]CP<K+,0:C#YP96!-"2,^,K#K=[8#KRG"O50[1$+,*'[U?
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M4:FE>ZA\ QU"#C/SA+:7I-$H>Y%A<24*;WGZ0%^0%U94$GQ;#6>M4YX%C3*
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M7XZ)_I[RKVQ$3"-1QT2Q!]6A(0_B$0G9!%HTY1%Y9>C?<2OGCP-7F%2(M,Y
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M34DVAIHI[\6!6]Z.!H%83W&S #FAV*5A?42A3R '@-VIG%?F'TFH/^.I7CB
M_5BLGR"EP8O$?"JKOH-,QQ1X6T(2T<XKXP/<C:;//:BGJJ5;89V01<7D(C(%
M0OHL0=(Q/@.\%0_RV0TY!2S.  0Q2(K*TC D*2"1J@Q T]9=0A;0D'@4USAJ
MOO (."3VYN4@/0*Z089(0?!\))3I4X0+CEN9A''$PDG@LW'$E<HAE6E3+GR[
MB%%(JF"(""5 X!7?*U1V(9L#Z+N+W@N*X9DEA4] 3Q8("(%\\@,]_H+II)R2
MM7\37;RT 0$>*Y__SD ,C6L-'1P:<K! \;Z$4I[#-&(PNY;A5.0+-2T22)Z
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MSC_AYN6^%<CA;EYNGEZ7SY6G[7<0EW=13X[PLJQ^*"[^_@-02P,$%     @
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M1"L2S3UX4,-8)-*>5/CJO*M4K]!0K7=S<,X^\;>VUDU)]9;3V?]02P,$%
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M+C"F4?T=R&TZ&_V@H06"AA8(WI,%]**^T0+!BP4@]_AL]'L-+=!K:('>>[*
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M7UG".[Y!_ 5]%Q$OXB_;'_\'4$L! A0#%     @ $6"U7!S(R1\E&   5XP
M !$              ( !     &5F,C P-S0T,S!?.&LN:'1M4$L! A0#%
M  @ $6"U7*S96FPJGP  ?M # !0              ( !5!@  &5F,C P-S0T
M,S!?97@Q+3$N:'1M4$L! A0#%     @ $6"U7",84=\D"@   2P  !0
M         ( !L+<  &5F,C P-S0T,S!?97@U+3$N:'1M4$L! A0#%     @
M$6"U7#-D#JM( P  2P\  !$              ( !!L(  '9I878M,C R-C U
M,3DN>'-D4$L! A0#%     @ $6"U7+=&\TQZ"   ,%8  !4
M ( !?<4  '9I878M,C R-C U,3E?;&%B+GAM;%!+ 0(4 Q0    ( !%@M5Q.
MGM;UX 4  /T^   5              "  2K.  !V:6%V+3(P,C8P-3$Y7W!R
;92YX;6Q02P4&      8 !@"( 0  /=0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>ef20074430_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="viav-20260519.xsd" xlink:type="simple"/>
    <context id="c20260519to20260519">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000912093</identifier>
        </entity>
        <period>
            <startDate>2026-05-19</startDate>
            <endDate>2026-05-19</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20260519to20260519"
      id="Fact_06b39c0d5a344643bdf0e8639d24e7a4">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="c20260519to20260519"
      id="Fact_b8b2517f44ba42f4bd63cf22aa23e11d">0000912093</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="c20260519to20260519"
      id="Fact_7d04a166a12d44c3b0dcb2c58fa4404b">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20260519to20260519"
      id="Fact_c14f77e49a114697b8456846f788c7bc">2026-05-19</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20260519to20260519"
      id="Fact_3db9bfd7a3d949c8b3ced214017fb435">VIAVI SOLUTIONS INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20260519to20260519"
      id="Fact_817cfa5ed55240f6a9e9cd5122dd57b6">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20260519to20260519"
      id="Fact_9d7548b001b24bc78d4a069a665e8b73">000-22874</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20260519to20260519"
      id="Fact_e934589b8f4d460a911af64b61886bb6">94-2579683</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20260519to20260519"
      id="Fact_4cc42160245f4a1a838f34c4390e0ccc">1445 South Spectrum Blvd</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="c20260519to20260519"
      id="Fact_2380dc9d9a2d4e5ebb4f7b81876626a6">Suite 102</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="c20260519to20260519"
      id="Fact_ea063b7550de48a491a564166fa8a3c2">Chandler</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="c20260519to20260519"
      id="Fact_89fbec9a53914bfcad0fc8458d92aab9">AZ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="c20260519to20260519"
      id="Fact_ebaf366464224195baed29bb416d8160">85286</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20260519to20260519"
      id="Fact_3e16b0217e4a48daa659ae8ace06988b">408</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20260519to20260519"
      id="Fact_4d75192b7f9c437da9561b8660ada95b">404-3600</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="c20260519to20260519"
      id="Fact_f76c329158f74765845ef50355b57f05">Common Stock, par value of $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20260519to20260519"
      id="Fact_d04cf18cc1bc450ea3e63457e7941aa9">VIAV</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="c20260519to20260519"
      id="Fact_f6f58141b59d430d8ea8244082c598e2">NASDAQ</dei:SecurityExchangeName>
    <dei:WrittenCommunications
      contextRef="c20260519to20260519"
      id="Fact_3222d84464664201a33c80a84e36b7ee">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20260519to20260519"
      id="Fact_7d06e729d4624a39be906b769e216b76">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20260519to20260519"
      id="Fact_1a9d6bf6eedc4f0fac757e8b925b744e">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20260519to20260519"
      id="Fact_ab8d514c8a114f63a66540863ad14283">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20260519to20260519"
      id="Fact_abee6deda7cc40cbb25a382d1f496b8a">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
